dihydrotestosterone has been researched along with Adenoma, Prostatic in 511 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 226 (44.23) | 18.7374 |
| 1990's | 111 (21.72) | 18.2507 |
| 2000's | 68 (13.31) | 29.6817 |
| 2010's | 78 (15.26) | 24.3611 |
| 2020's | 28 (5.48) | 2.80 |
| Authors | Studies |
|---|---|
| Ács, K; Balázs, VL; Csikós, E; Dolenc, MS; Farkas, Á; Horváth, A; Horváth, G; Kenda, M; Kočevar Glavač, N; Mercolini, L; Nagy, M; Papp, N; Protti, M | 1 |
| Gahan, JC; Henry, GH; Hutchinson, RC; Joseph, DB; Malewska, A; Mauck, RJ; Mohler, JL; Reese, JC; Roehrborn, CG; Strand, DW | 1 |
| Goudarzi, M; Kalantar, H; Kalantar, M; Kalantari, H; Mansouri, E; Shabani, E | 1 |
| Ateya, AI; Ezz, MA; Fehaid, A; Marghani, BH; Saleh, RM | 1 |
| An, HJ; Jin, BR; Kim, BH; Kim, HJ; Park, SJ | 1 |
| Cai, Y; Chen, Z; Huang, B; Huang, J; Li, L; Liu, X; Wu, B; Wu, D; Zhan, H; Zhang, S | 1 |
| An, J; Kong, H | 1 |
| Burke, S; Case, T; Cates, JM; Forbes, C; Jin, R; Kim, HH; Mantione, KM; Matusik, RJ; Miller, NL; Mohler, JL; Porter, NA; Strand, D; Wages, P | 1 |
| Bae, SM; Choi, YJ; Fan, M; Hwang, JY; Kim, EK; Tang, Y; Wedamulla, NE | 1 |
| Jang, YJ; Jung, HY; Kim, D; Kwon, J; Myeong, JY; Park, JI; Song, KH | 1 |
| Aoyama, T; Fujita, T; Heijou, H; Morimoto, K; Takeshita, S; Uemura, T; Yamasaki, T | 1 |
| Arias-Chávez, DJ; Bravo, G; Campos-Pérez, E; Ledesma-Aparicio, J; Mailloux-Salinas, P; Medina-Campos, ON; Pedraza-Chaverri, J | 1 |
| Abdelfattah, HA; Almoatasem, MAM; Almutairi, SM; Elkhamisy, FAA; Elshaer, MMA; Embaby, AS; Hussein, DS; Khattab, RT; Rasheed, RA; Sadek, AS | 1 |
| Abbaszadeh-Hasiri, M; Ahrari Khafi, MS; Derakhshandeh, N; Golchin-Rad, K; Mogheiseh, A; Nazifi, S | 2 |
| Cho, K; Hong, GL; Jung, DY; Jung, JY; Karunasagara, S; Koh, EJ; Lee, KP; Park, SR; Park, SS | 1 |
| Günzel-Apel, AR; Rohn, K; Schmicke, M; Schuler, G; Urhausen, C; Werhahn Beining, F; Wolf, K | 1 |
| Chen, CW; Hsieh, RH; Lin, YL; Tsai, HH; Yu, PL | 1 |
| An, HJ; Jin, BR | 1 |
| Gharaghani, S; Hassan, A; Mando, H | 1 |
| Chen, S; Hu, Y; Huang, Y; Jiang, Z; Liu, J; Lu, Q; Wang, H; Yang, T; Yin, X; Zhou, Y | 1 |
| Alfajaro, MM; Cho, KO; Choi, J; Choi, US; Jang, Y; Je, H; Jung, J; Yoon, S | 1 |
| Angrimani, DSR; Brito, MM; Nichi, M; Rui, BR; Vannucchi, CI | 1 |
| An, YJ; Jun, W; Kim, Y; Lee, JY; Lee, YH | 1 |
| Angrimani, DSR; Flores, RB; Lima, CB; Vannucchi, CI | 1 |
| Aizawa, T; Kumaki, Y; Kusama, K; Kuwabara, N; Miyagawa, M; Miyaoka, H; Nakasone, T; Ohnishi, Y; Okamatsu, S; Ota, K; Saeki, K; Tamura, K | 1 |
| An, HJ; Jin, BR; Kim, HJ | 1 |
| Go, C; Jo, H; Kang, D; Kang, JS; Kim, Y; Lee, D; Yang, J | 1 |
| An, J; Cao, Y; Li, Y; Lin, S; Ma, X; Wang, S; Xu, L; Yang, M; Yuan, J; Zhang, Y; Zhao, Y | 1 |
| Čekerevac, M; Dragičević, D; Džamić, Z; Kozomara, M; Milković, B; Pejčić, T; Tešić, Ž; Tosti, T | 1 |
| Cordaro, M; Cuzzocrea, S; Di Paola, R; Esposito, E; Fusco, R; Gugliandolo, E; Impellizzeri, D; Inferrera, A; Siracusa, R | 1 |
| Jeon, WY; Jin, SE; Kim, JA; Kim, OS; Kim, YU; Lee, MY; Seo, CS; Shin, HK | 1 |
| Jung, HJ; Moon, JM; Seo, JW; Sung, HM; Wee, JH | 1 |
| Botto, H; Dreyfus, JF; Fiet, J; Ghoneim, TP; Giton, F; Lebret, T; Neuzillet, Y; Radulescu, C; Raynaud, JP | 1 |
| Bechis, SK; Ge, R; Hu, L; Olumi, AF; Pham, J; Rassoulian, C; Salari, K; Strand, DW; Tabatabaei, S; Wang, Z; Wu, CL; Wu, S | 1 |
| Jeong, HY; Kwun, HJ; Lim, JH; Moon, OS; Park, HS; Seo, YW; Son, HY; Song, JW; Ub Wijerathne, C; Won, YS; Yeon, SH | 1 |
| Allifranchini, E; Bocchietto, E; Detering, M; Koyyalamudi, SR; Steels, E; Vitetta, L | 1 |
| Liss, MA; Thompson, IM | 1 |
| Jung, JY; Kim, HT; Kim, YJ; Park, SR; Ryu, SY | 1 |
| Han, B; Jiang, C; Jing, Y; Luo, G; Shi, F; Wang, X; Xia, S; Yang, B; Zhao, R; Zhu, Y; Zhuo, J | 1 |
| Drobnis, EZ; Nangia, AK | 1 |
| Jeon, WY; Lee, MY; Park, E; Seo, CS; Shin, HK; You, S | 1 |
| Campolo, M; Cordaro, M; Cuzzocrea, S; Esposito, E; Filippone, A; Paterniti, I; Siracusa, R | 1 |
| Refaie, MMM; Rifaai, RA; Zenhom, NM | 1 |
| Büyükalpelli, R; Diri, B; Diri, MA; Yildiz, L | 1 |
| Jia, DY; Li, R; Li, Z; Luo, SY; Xu, DR | 1 |
| An, HJ; Jin, BR; Kim, HJ; Kim, MS; Lee, KH; Park, SK; Yoon, IJ | 1 |
| Arnica, S; Buonocore, D; Cattaneo, L; Dossena, M; Ghitti, M; Verri, M | 1 |
| Botto, H; Dreyfus, JF; Fiet, J; Ghoneim, T; Giton, F; Lebret, T; Meunier, ME; Neuzillet, Y; Radulescu, C; Raynaud, JP; Rouanne, M | 1 |
| Jeong, HY; Kwun, HJ; Moon, OS; Park, HS; Rho, J; Seo, CS; Seo, YW; Son, HY; Wijerathne, CU; Won, YS | 1 |
| Baek, DH; Kang, SC; Kim, CW; Koo, YT; Kwon, JE; Lee, SH; Negi, M; Noh, YH; Park, BK | 1 |
| Culig, Z; Madersbacher, S; Sampson, N | 1 |
| Luo, WZ; Su, RN; Wang, L; Wei, RR; Zhong, GY; Zhu, JX | 1 |
| An, HJ; Bae, SJ; Chung, TW; Ha, KT; Jin, BR; Jin, L; Kim, EY; Park, H; Ryu, D | 1 |
| Chen, MH; Chen, YL; Chiu, HW; Fang, WH; Hung, CM; Wang, YJ; Wu, MD; Wu, MJ; Yuan, GF | 1 |
| Li, M; Wang, H; Xi, Z; Xu, E; Yang, X | 1 |
| Honda, M; Kinoshita, Y; Oikawa, R; Saito, M; Sejima, T; Shimizu, S; Tomita, S; Tsounapi, P | 1 |
| Given, L; Harisaran, V; Kacker, R; Miner, M; Morgentaler, A; Rittmaster, R | 1 |
| Kyoung, H; Lee, MY; Seo, CS; Shin, HK; Shin, IS; Son, JK | 1 |
| Cui, Y; Fan, Y; He, Q; Hu, S; Jin, J; Li, X; Liu, J; Lv, T; Sun, M; Xiao, F; Yu, W | 1 |
| Barai, RS; Chaudhari, UK; Fernandes, G; Jacob, S; Kholkute, SD; Menon, S; Nayak, S; Sachdeva, G | 1 |
| Hsieh, YW; Kao, CH; Lin, CL; Lin, WL; Sung, FC; Wu, CH | 1 |
| Adjei, S; Afriyie, DK; Asare, GA; Bugyei, K; Hong, ZF; Lin, JM; Peng, J | 1 |
| Chhabra, M; Dalela, D; Goel, A; Goel, MM; Natu, SM; Rajender, S; Tewari, R | 1 |
| Chen, KC; Chyau, CC; Lin, YT; Peng, CC; Peng, RY | 1 |
| Dastgheib, L; Dehghan, S; Moezzi, I; Sadati, MS; Shirazi, M | 1 |
| Efremov, GD; Kabanova, IV; Kirpatovskii, VI; Mkrtchyan, KG; Mudraya, IS; Nadtochii, ON; Revenko, SV | 1 |
| An, HJ; Cheon, SY; Chung, KS; Kwon, KR; Lee, KH | 1 |
| Cha, JY; Chang, BC; Choi, YL; Hong, GS; Jang, Y; Jung, J; Lee, B; Lee, HY; Lee, MO; Min, HY; Na, TY; Oh, U; Shin, YK; Wee, J | 1 |
| Chen, HG; Deng, QF; Gong, XJ; Hu, EM; Huang, Y; Jiang, ZM; Wu, XD; Zhao, C; Zhou, X | 1 |
| Bratoeff, E; Cabeza, M; Garrido, M; Sánchez-Márquez, A; Silva, A | 1 |
| Izumi, K; Kitagawa, Y; Koh, E; Miyagi, T; Mizokami, A; Nakashima, T; Namiki, M; Shigehara, K; Shimamura, M | 1 |
| An, HJ; Chung, KS; Jeon, HJ | 1 |
| An, HJ; Cheon, SY; Chung, KS; Lee, NY; Park, W; Shin, SJ; Sun, SH | 1 |
| An, HJ; Cheon, SY; Chung, KS; Kim, CY; Lee, JH; Park, YB | 1 |
| Eleazu, C; Ijeh, II; Kalu, WO; Okafor, PN | 1 |
| El-Sahar, AE; Saad, MA; Sayed, RH | 1 |
| Harada, M; Honma, S; Kubota, Y; Miyoshi, Y; Shibata, Y; Suzuki, K; Uemura, H | 1 |
| An, HJ; Cheon, SY; Chung, KS; Eom, JH; Kim, MD | 1 |
| Cui, Y; Fan, Y; Han, W; He, Q; Hu, S; Jin, J; Li, J; Liu, J; Liu, L; Lv, T; Sun, Y; Yang, Y; Yu, W | 1 |
| Acevedo, C; Cabezas, J; Castellón, EA; Contreras, HR; Huidobro, C; Mendoza, P; Noé, G; Sánchez, C; Vergara, J | 1 |
| Hahn, RG; Ray, P; Rittmaster, R; Shannon, JB; Wurzel, R | 1 |
| Chorzepa-Nowicka, K; Gaczarzewicz, D; Laszczyńska, M; Piasecka, M; Wylot, M | 1 |
| Alcaraz, A; Castro, R; Desgrandchamps, F; Hammerer, P; Montorsi, F; Schröder, F | 1 |
| Gao, YR; Handelsman, DJ; McNamara, K; Simanainen, U | 1 |
| Acquaro, C; Carvalho, RF; Felisbino, SL; Justulin, LA; Silva, MD | 1 |
| Hessels, D; Mulders, PF; Peelen, WP; Schalken, JA; van Gils, MP; Vergunst, H | 1 |
| Barrett-Connor, E; Bergstrom, J; Lakin, C; Palazzi-Churas, K; Parsons, JK; Trifiro, MD | 1 |
| Hori, S; Ohtani, H; Satoh, H; Sawada, Y; Suzuki, R | 1 |
| Barrett-Connor, E; Bergstrom, J; Palazzi-Churas, K; Parsons, JK | 1 |
| Exintaris, B; Kusljic, S | 1 |
| Hong, JH; Kang, HS; Kim, JH; Park, HG; Ro, JY; Song, HY; Yoon, CJ | 1 |
| Brandner, R; Djavan, B; Eckersberger, E; Espinosa, G; Finkelstein, J; Lepor, H; Sadri, H; Shah, O | 1 |
| Conway, AJ; Griffiths, KA; Handelsman, DJ; Harwood, DT; Idan, A; Seibel, MJ; Turner, L | 1 |
| Dušková, M; Pospíšilová, H | 1 |
| Dalela, D; Gupta, G; Jain, A; Jain, RK; Kumar, R; Maikhuri, JP; Sarswat, A; Sharma, VL; Verma, V | 1 |
| Chiang, HS; Chung, SD; Li, HY; Liao, CH; Yu, HJ | 1 |
| He, GL; Jiang, XR; Liu, GM; Liu, XY; Sun, ZY; Wu, JH | 1 |
| Chang, HC; Chen, SC; Hsieh, JT; Yu, HJ | 1 |
| Chiang, HS; Liao, CH; Yu, HJ | 1 |
| Blankenstein, MA; Bui, HN; Heijboer, AC; Meuleman, EJ; van der Sluis, TM; van Moorselaar, RJ; Vis, AN | 2 |
| Ha, HK; Lee, MY; Lee, NH; Seo, CS; Shin, HK; Shin, IS; Son, JK | 1 |
| Ha, HK; Jung, DY; Lee, MY; Seo, CS; Shin, HK; Shin, IS | 1 |
| Hashim, H; Ismail, M | 1 |
| Chen, J; Han, P; Ruan, JL; Song, SS; Xiong, CM | 1 |
| Ha, HK; Lee, MY; Seo, CS; Shin, HK; Shin, IS | 1 |
| Adorini, L; Carini, M; Cellai, I; Comeglio, P; Filippi, S; Gacci, M; Logiodice, F; Lombardelli, L; Maggi, M; Morelli, A; Nesi, G; Piccinni, MP; Santi, R; Vignozzi, L | 1 |
| Ejike, CE; Ezeanyika, LU | 1 |
| Adomat, HH; Bains, OS; Gleave, ME; Grigliatti, TA; Guns, ES; Lubieniecka, JM; Reid, RE; Riggs, KW | 1 |
| Delella, FK; Felisbino, SL; Lacorte, LM; Martins, M; Moroz, A; Rinaldi, JC; Sarobo, C; Scarano, WR | 1 |
| Gsur, A; Haidinger, G; Haitel, A; Madersbacher, S; Marberger, M; Micksche, M; Preyer, M; Schatzl, G; Vutuc, C | 1 |
| Andriole, G; Boyle, P; Hoefner, K; Nickel, JC; Roehrborn, CG | 1 |
| Dulińska, J; Labedź, M; Laidler, P | 1 |
| Bales, WD; Epstein, JI; Fan, J; Macairan, ML; Marks, LS; Miller, MC; Partin, AW; Veltri, RW | 1 |
| Bartsch, G; Klocker, H; Rittmaster, RS | 3 |
| Choi, MH; Chung, BC; Kim, JN | 1 |
| Pham, H; Ziboh, VA | 1 |
| Kanetake, H; Sakai, H | 1 |
| Han, RF; Ma, TX; Niu, YJ; Sun, G; Xu, Y; Zhang, J | 1 |
| Carson, C; Rittmaster, R | 1 |
| Benghuzzi, HA; Pollan, MC; Tucci, M | 2 |
| Jarred, RA; Jones, ME; McPherson, SJ; Risbridger, GP; Simpson, ER | 1 |
| Adorini, L; Bettuzzi, S; Caporali, A; Comerci, A; Crescioli, C; Ferruzzi, P; Maggi, M; Mancina, R; Mariani, R; Muratori, M; Scaltriti, M; Serio, M; Smiroldo, S; Vannelli, GB; Villari, D | 1 |
| Batra, SK; Bryan, M; Karan, D; Lin, FC; Lin, MF; Moniaux, N; Ringel, J | 1 |
| He, GL; Liu, GM; Sun, ZY; Wu, JH; Zhong, EH; Zhu, Y | 1 |
| Constantinou, CE; Gotanda, K; Honda, K; Nomiya, M; Tsuruya, Y; Yamaguchi, O; Yokota, T | 1 |
| Assinder, SJ; Nicholson, HD | 1 |
| Akl, P; Herington, AC; McCulloch, DR; Odorico, DM; Samaratunga, H | 1 |
| Egawa, M; Fujita, H; Honma, S; Keller, ET; Koh, E; Koshida, K; Maeda, Y; Mizokami, A; Namiki, M | 1 |
| Foster, CS; Ke, Y; Rhodes, NP; Smith, P | 1 |
| Schalken, JA | 1 |
| Clark, RV; Cunningham, GR; Hermann, DJ; Hobbs, S; Morrill, BB; Wilson, TH | 1 |
| Hoa Huynh, T; Hung Nguyen, T; Huynh, H; Ma, Z; Tien Do, P | 1 |
| Ciccarelli, A; Colao, A; Di Sarno, A; Guerra, E; Lombardi, G; Spiezia, S; Vitale, G | 1 |
| Banerjee, T; Pham, H; Ziboh, VA | 1 |
| Barkin, J; Debruyne, F; Reis, M; Roehrborn, C; Tammela, TL; van Erps, P | 1 |
| Andriole, G; Bruchovsky, N; Chung, LW; Matsumoto, AM; Rittmaster, R; Roehrborn, C; Russell, D; Tindall, D | 1 |
| Barton, AB; Barton, BE; Huang, HF; Murphy, TF; Shu, P | 1 |
| Higashi, T; Koh, E; Mizokami, A; Namiki, M; Shimada, K; Yamauchi, A | 1 |
| Abrahamsson, PA; Ahlgren, G; Gadaleanu, V; Giwercman, A; Giwercman, YL | 1 |
| Ichikawa, T; Komiya, A; Suzuki, H | 1 |
| Higashi, T; Shimada, K; Yamauchi, A | 1 |
| Babkina, TV; Degtyar, VG; Kazantseva, IA; Kushlinskii, NE; Morozov, AP; Trapeznikova, MF | 1 |
| Botto, H; Comenducci, A; Lan, O; Poulain, JE | 1 |
| Marks, LS | 1 |
| Ray, P; Roehrborn, CG | 1 |
| Dobi, A; Drukier, A; Gao, CL; Gu, Y; Kim, KH; Li, H; Masuda, K; Rhim, JS; Shaheduzzaman, S; Srikantan, V; Srivastava, S | 1 |
| Major-Walker, K; Ray, P; Rittmaster, R; Shannon, J; Wurzel, R | 1 |
| Chung, MK; Emberton, M; Gittelman, M; Madersbacher, S; Michel, MC; Zinner, N | 1 |
| Cunningham, GR; Ittmann, M; Li, H; Shao, TC | 1 |
| Arima, T; Chiyomaru, T; Enokida, H; Idesako, T; Kagara, I; Kubo, H; Matsuda, R; Nakagawa, M; Nishimura, H; Nishiyama, K; Tatarano, S; Toki, K | 1 |
| Bisson, JF; Hidalgo, S; Messaoudi, M; Rozan, P | 1 |
| Gomes Soares, DF; Koff, WJ; Muraro, F; Oliveira, OL; Santos, EB; Trindade, VM | 1 |
| Marks, LS; Mostaghel, EA; Nelson, PS | 1 |
| Bartsch, G; Heilbronner, R; Oberholzer, M; Rohr, HP | 1 |
| Chu, TM; Kirdani, RY; Murphy, GP; Saroff, J; Wajsman, Z | 1 |
| Belis, JA | 1 |
| Wilson, JD | 3 |
| De Slypere, JP; Sayed, MA; Van Camp, K; Van Sande, M; Verdonck, L; Vermeulen, A | 1 |
| Kadohama, N; Sandberg, AA | 1 |
| Kodama, T; Shimazaki, J; Wakisaka, M | 1 |
| Finney, RW; Gaskell, SJ; Griffiths, K; Harper, ME | 1 |
| Edmiston, A; Horton, R; Morimoto, I | 1 |
| Hasebe, C; Kodama, T; Shimazaki, J | 1 |
| Cowan, SK; Glen, ES; Grant, JK; Janeczko, AE; Sirett, DA | 1 |
| Collier, ES; Fang, SM; Meikle, AW; Middleton, RG | 1 |
| Bercovich, E; De Giovanni, C; Galli, MC; Grilli, S; Martelli, A; Prodi, G; Soli, M | 1 |
| Lukkarinen, O | 1 |
| Habib, FK | 1 |
| Bénard, B; Elhilali, M; Lehoux, JG | 1 |
| Coffey, DS; Isaacs, JT | 2 |
| Baranowska, B; Szymanowski, J; Zgliczynski, S | 2 |
| Morfin, RF; Thouvenot, D | 1 |
| Ghanadian, R; Masters, JR; Smith, CB | 1 |
| Ghanadian, R; Puah, CM | 2 |
| Hammond, GL; Kontturi, M; Lukkarinen, O; Vihko, R | 1 |
| Collier, ES; Fang, SM; Meikle, AW; Stringham, JD; Taylor, GN | 1 |
| Brown, JR; Cartagena, R; Farnsworth, WE; Gonder, MJ; Oseko, F; Sharma, M; Slaunwhite, WR | 1 |
| Ghanadian, R; McWhinney, N; Puah, CM; Shah, PJ; Williams, G | 1 |
| Hudson, RW | 3 |
| Connolly, JG; Johnson, IE; Mobbs, BG | 3 |
| Ito, H; Maruoka, M; Nozumi, K; Sato, R; Shimazaki, J | 1 |
| Cochran, RC; Ewing, LL; Niswender, GD | 1 |
| Busuttil, A; Chisholm, GD; Habib, FK; Tesdale, AL | 1 |
| Albert, J; Geller, J; Geller, S; Loza, D; Nachtsheim, DA | 1 |
| Bujnovszky, P; Trachtenberg, J; Walsh, PC | 1 |
| Buniatrian, AF; Gerasimova, TsI; Smirnov, AN | 1 |
| Auf, G; Ghanadian, R | 1 |
| Bolton, NJ; Kontturi, M; Lahtonen, R; Vihko, P; Vihko, R | 1 |
| Hein, HJ; Romijn, JC; Schröder, FH; Schweikert, HU | 1 |
| Battersby, S; Griffiths, K; Harper, ME; Syms, AJ | 1 |
| Bruchovsky, N; McLoughlin, MG; Rennie, PS; To, MP | 1 |
| Russell, DH | 1 |
| Isurugi, K; Kambegawa, A; Kanazawa, M; Yanaihara, T | 1 |
| Ito, H; Kodama, T; Maruoka, M; Matsumura, T; Miyauchi, T; Naito, H; Nozumi, K; Sato, R; Shimazaki, J; Wakisaka, M | 1 |
| Hikage, T; Ito, H; Kodama, T; Sato, R; Shimazaki, J | 1 |
| Bartsch, W; Becker, H; Krieg, M; Mohrmann, J; Voigt, KD | 1 |
| Neumann, F; Ruberg, I; Senge, T | 1 |
| Kanbegawa, A; Mitsuhata, N; Morioka, M; Ohashi, T; Ohmori, H; Saito, T; Takeda, K | 1 |
| Brendler, CB; Isaacs, JT; Walsh, PC | 1 |
| Griffin, JE; Wilbert, DM; Wilson, JD | 1 |
| Drafta, D; Neacşu, E; Proca, E; Schindler, AE; Stroe, E; Zamfir, V | 1 |
| Arvis, G | 1 |
| Horton, R | 3 |
| Kitano, T; Miyachi, Y; Nakahara, M; Nihira, H; Usui, T; Yasukawa, A | 1 |
| Bolton, NJ; Kontturi, M; Lahtonen, R; Vihko, R | 1 |
| Beauchesne, C; Bénard, B; Carmel, M; Elhilali, M; Lehoux, JG; Madarnas, P; Mongeau, C; Tétreault, L | 1 |
| Bruchovsky, N; Djøseland, O; Høglo, S; Otal, N; Rennie, PS | 1 |
| Isaacs, JT | 2 |
| Blondeau, JP; Dadoune, JP; Eychenne, B; Groyer, MT; Hechter, O; Jung-Testas, I; Mercier-Bodard, C; Robel, P; Roux, C | 1 |
| Bartsch, W; Krieg, M; Thomsen, M; Voigt, KD | 1 |
| Killinger, DW; Perel, E | 1 |
| Bassalyk, LS; Degtiar', VG; Kushlinskiĭ, NR | 1 |
| Dörner, G; Geier, T; Poppe, I; Rohde, W; Schnorr, D; Stahl, F | 1 |
| Hudson, RW; Moffitt, PM; Owens, WA | 1 |
| Ewing, LL; Hutchins, GM; Walsh, PC | 1 |
| Berry, SJ; Ewing, LL; Higginbottom, EG | 1 |
| Bolton, NJ; Lahtonen, R; Lukkarinen, O; Vihko, R | 1 |
| Bartsch, G; Bruengger, A; Hollinger, BE; Holly, B; Rohr, HP | 1 |
| Busuttil, A; Chrisholm, GD; Habib, FK; Leake, A | 1 |
| Alroy, J; Merk, FB; Orgad, U; Ucci, A | 1 |
| Kirdani, RY; Murphy, GP; Pontes, EJ; Sandberg, AA | 1 |
| Charles, JF; Floch, HH; Morfin, RF; Sinquin, G | 1 |
| Walsh, PC | 2 |
| Tomioka, O | 1 |
| Kosaku, N; Makino, T; Shida, K; Yamanaka, H | 1 |
| Fujita, Y; Morioka, M; Ohashi, T; Ohashi, Y; Ohmori, H; Takeda, K; Tojo, S | 1 |
| Bol'shakova, TD; Buniatian, AF; Gerasimova, TsI; Rozen, VB; Smirnov, AN | 1 |
| Pachman, A | 1 |
| Holló, I; Horváth, C | 1 |
| Chang, CH; Murthy, LR; Rowley, DR; Scardino, PT; Tindall, DJ | 1 |
| Bélanger, A; Dubé, JY; Frenette, G; Labrie, F; Tremblay, RR; Tremblay, Y | 1 |
| Fukabori, Y; Hamataki, N; Honma, S; Ito, K; Kushitani, M; Mieda, M; Suzuki, K; Takezawa, Y; Yamanaka, H | 1 |
| Grino, P; Stoner, E | 1 |
| Stoner, E | 1 |
| Corr, JG; Fair, WR; Heston, WD; Israeli, RS; Powell, CT | 1 |
| Akimoto, S; Ichikawa, T; Kitagawa, N; Shimazaki, J | 1 |
| Buscarini, M; Caponera, M; D'Eramo, G; Di Silverio, F; Flammia, GP; Frascaro, E; Mariani, M; Sciarra, A | 1 |
| Ballard, SA; Masters, JR; Smith, CM; Wyllie, MG | 1 |
| Berry, SJ; Coffey, DS; Ewing, LL; Juniewicz, PE; Strandberg, JD | 1 |
| Baird, A; Connors, KM; Geller, J; Hoffman, RM; Kohls, M; Sionit, LR | 1 |
| Gilad, S; Jaffe, A; Matzkin, H; Stern, N | 1 |
| Gormley, GJ; Stoner, E | 1 |
| Gann, PH; Grodstein, F; Hennekens, CH; Longcope, C; Stampfer, MJ; Verhoek-Oftedahl, W | 1 |
| Cohen, SM; Harris, G; Jacobs, JG; Malatesta, PF; Nett, TM; Prahalada, S; Rasmusson, GH; Tanaka, WK; Werrmann, JG | 1 |
| Janssen, T; Kiss, R; Schulman, C | 1 |
| Eri, LM; Haug, E; Tveter, KJ | 1 |
| Sane, T | 1 |
| Dell'Orto, P; Gelosa, M; Guarneri, A; Montanari, E | 1 |
| Boni, S; Chiodera, P; Coiro, V; Maccarini, PA; Volpi, R | 1 |
| Bosland, MC; Falvo, RE; Liehr, JG; Nagamani, M; Wade, DR; Winter, ML | 1 |
| Claes, H; De Jaegher, K; Kozyreff, P | 1 |
| Steers, WD; Zorn, B | 1 |
| Sciarra, F | 1 |
| Krieg, M; Tunn, S; Weisser, H | 1 |
| McConnell, JD | 1 |
| Fujita, M; Hori, T; Kawakami, E; Ogasa, A; Orima, H; Shimizu, M; Tsutsui, T | 1 |
| Chisholm, GD; Habib, FK; Yang, Y | 2 |
| Geller, J | 5 |
| Ball, RA; Leder, P; Ornitz, DM; Richie, JP; Tutrone, RF | 1 |
| de Lignieres, B | 1 |
| Krieg, M; Nass, R; Tunn, S | 1 |
| Bryan, J; Holmes, K; Kirby, RS; Vale, J; Webb, JA | 1 |
| Kawakami, E; Makanae, Y; Ogasa, A; Orima, H; Shimizu, M; Tsutsui, T; Yajima, K | 1 |
| Coakes, KE; Norman, RW; Rittmaster, RS; Wright, AS | 1 |
| Härkönen, PL; Martikainen, PM; Nevalainen, MT; Nurmi, M; Ping, W; Valve, EM | 1 |
| Ahn, H; Kassen, A; Kozlowski, JM; Lee, C; Sensibar, JA; Sutkowski, DM | 1 |
| Liehr, JG; Winter, ML | 1 |
| Norman, RW; Rittmaster, RS; Rowden, G; Thomas, LN | 1 |
| Hampl, R; Hill, M; Petrík, R; Stárka, L | 2 |
| Igawa, M; Ishibe, T; Shiina, H | 2 |
| Beaulieu, M; Bélanger, A; Bélanger, G; Guillemette, C; Hum, DW; Lévesque, E; Marcotte, B | 1 |
| Constantinou, CE; Omata, S | 1 |
| Jenkin, L; Nicholson, HD | 1 |
| Boudon, C; Gibelin, B; Lechevallier, E; Lobaccaro, JM; Lumbroso, S; Mottet, N; Sultan, C | 1 |
| Berg, S; Greenspan, SL; Rosen, HN; Saltzman, B; Tollin, SR; Zeind, AJ; Zurowski, K | 1 |
| Adamo, MV; d'Eramo, G; di Silverio, F; Monti, S; Palma, E; Sciarra, F; Toscano, V | 1 |
| Igawa, M; Ishibe, T; Shiina, H; Shirakawa, H; Urakami, S; Usui, T | 1 |
| Sherwood, LM | 1 |
| Hampl, R; Hill, M; Lapcík, O; Stárka, L | 1 |
| Assenmacher, C; Corbusier, A; De Decker, R; Janssen, T; Kiss, R; Pasteels, JL; Petein, M; Schulman, C; van Velthoven, R | 1 |
| Chisholm, GD; Habib, FK; Ross, M; Tate, R | 1 |
| Cunningham, GR; Marcelli, M; Padayatty, SJ; Shao, TC | 1 |
| deKernion, JB; Dorey, FJ; Garris, JB; Gormley, GJ; Marks, LS; Partin, AW; Shery, ED; Stoner, E; Subong, EN | 1 |
| Bílek, R; Hampl, R; Hill, M; Lapcík, O; Petrik, R; Stárka, L | 1 |
| Anselmo, G; Buoro, S; Conconi, MT; De Angeli, S; Fandella, A; Favretti, C; Parnigotto, PP | 1 |
| Collins, AT; Neal, DE; Robinson, EJ; Robson, CN | 1 |
| Lewis, CM; Meikle, AW; Middleton, RG; Stephenson, RA; Wiebke, GA | 1 |
| Adami, HO; Mantzoros, CS; Signorello, LB; Stampfer, M; Trichopoulos, D; Tzonou, A | 1 |
| Didolkar, V; Ding, VD; Feeney, WP; Moller, DE; Nakhla, AM; Rhodes, L; Rosner, W; Smith, RG | 1 |
| Constantinou, CE; Lee, JZ; Omata, S; Perkash, I; Tillig, B | 1 |
| Dulińska, J; Gałka, M; Laidler, P; Mrozicki, S; Ostrowski, WS | 1 |
| Altuğ, U; Arik, AI; Erol, D; Uygur, MC | 1 |
| Grayhack, JT; Ilio, KY; Kasjanski, RZ; Kozlowski, JM; Lee, C; Sensibar, JA | 1 |
| Kim, HN; Kim, SJ; Kwon, DD; Moon, JD; Oh, BR; Park, YI; Ryu, SB; Won, YH | 1 |
| Kurokawa, K; Mamiya, Y; Okazaki, H; Ono, Y; Onuma, E; Suzuki, K; Suzuki, T; Takanashi, H; Yamanaka, H | 1 |
| D'Eramo, G; Di Nicola, S; Di Silverio, F; Lanzara, S; Martini, C; Monti, S; Sciarra, A; Toscano, V; Varasano, PA | 1 |
| Bayne, CW; Bollina, P; Buck, C; Chapman, K; Donnelly, F; Habib, FK; Ross, M | 1 |
| Casale, P; Di Silverio, F; Monti, S; Sciarra, A; Seccareccia, F | 1 |
| Sun, ZY; Tu, ZH; Wang, MY; Wu, HY | 1 |
| Fukuda, Y; Fukuta, Y; Higashino, R; Ogishima, M; Takei, M; Tamaki, H; Yoshida, K | 1 |
| Fukabori, Y; Itoh, N; Kan, M; Lu, W; McKeehan, WL; Nakano, K; Yamanaka, H | 1 |
| Colciago, A; Motta, M; Negri-Cesi, P; Poletti, A | 1 |
| Ablondi, F; Banchini, A; Benedetti, R; Cecchetti, A; Cortellini, P; Denti, L; Ferretti, S; Pasolini, G; Sanfelici, L; Valenti, G | 1 |
| Fukabori, Y; Gotanda, K; Honma, S; Ito, K; Mieda, M; Shibata, Y; Suzuki, K; Yamanaka, H | 1 |
| Ahidouch, A; Authie, D; Beauvillain, JC; Carpentier, F; Cousse, H; Croix, D; Dewailly, E; Dupouy, JP; Fournier, S; Le Bourhis, X; Legrand, G; Prevarskaya, N; Raynaud, JP; Slomianny, C; Van Coppenolle, F | 1 |
| Fukabori, Y; Ito, K; Shibata, Y; Suzuki, K; Yamanaka, H | 1 |
| Di Silverio, F; Falasca, P; Iraci, R; Lanzara, S; Martini, C; Monti, S; Poggi, M; Sciarra, F; Stigliano, A; Toscano, V | 1 |
| Johnston, GR; Johnston, SD; Kustritz, MV; Memon, MA; Sarkar, DK; Sirinarumitr, K | 1 |
| Cruz Santos, PB; Dorey, FJ; Hess, DL; Luz Macairan, M; Marks, LS; Tyler, VE | 1 |
| Adams, JY; Alroy, J; Leav, I; Merk, FB; Schelling, KH | 2 |
| Iismaa, TP; Jones, ME; McPherson, SJ; Pedersen, J; Risbridger, GP; Simpson, ER; Wang, H; Wreford, N | 1 |
| Ford, OH; French, FS; Gregory, CW; He, B; Johnson, RT; Mohler, JL; Wilson, EM | 1 |
| Du, DL; Tang, XD; Wang, WZ; Xia, SJ; Xu, CX | 1 |
| Hartmann, RW; Jose, J; Michel, A; Reichert, W | 1 |
| Steers, WD | 1 |
| Barone, D; Bruzzese, T; Peroglio, F; Toso, E | 1 |
| Ding, Q; Fang, Z; Shi, D; Yao, M; Ye, L; Zhang, Y | 1 |
| Bercovici, JP; Charles, JF; Morfin, R | 1 |
| Dennis, M; Horst, HJ; Kaufmann, J; Voigt, KD | 1 |
| Altwein, JE; Orestano, F | 1 |
| Ansell, ID; Chisholm, GD; Ghanadian, R | 1 |
| Dawson, JB; Habib, FK; Hammond, GL; Stitch, SR | 1 |
| Baulieu, EE; Jung, I; Robel, P; Rosen, V | 1 |
| Albert, J; Cantor, T; Geller, J | 1 |
| Ito, Y; Nagai-Yuasa, H; Shida, K; Shimazaki, J; Yamanaka, H | 1 |
| Lloyd, JW; Mawhinney, MG; Thomas, JA | 1 |
| Habib, FK; Stitch, SR | 1 |
| Lasnitzki, I; Whitaker, RH; Withycombe, JF | 1 |
| Ito, Z; Shida, K; Yamanaka, H | 1 |
| Bonne, C; Raynaud, JP | 1 |
| Kaufmann, J | 1 |
| Attramadal, A; Djöseland, O; Hansson, V; Naess, O; Torgersen, O; Tveter, KJ; Weddington, SC | 1 |
| Horst, HJ; Krieg, M; Voigt, KD | 1 |
| Brassinne, C; Hawkins, EF; Nijs, M | 1 |
| Baulieu, EE; Marchut, M; Mercier-Bodard, C; Perrot, M; Picard, MT; Robel, P | 1 |
| Walsh, PC; Wilson, JD | 1 |
| Brown, JR; Farnsworth, WE | 1 |
| Albert, J; Geller, J; Geller, S; Lopez, D; Niwayama, G | 1 |
| Cowan, RA; Cowan, SK; Giles, CA; Grant, JK | 1 |
| Dawson, JB; Habib, FK; Hammond, GL; Lee, IR; Mason, MK; Smith, PH; Stitch, SR | 1 |
| Habib, FK; Lee, IR; Smith, PH; Stitch, SR | 1 |
| Daly, JJ; Griffin, PP; Kliman, B; Maclaughlin, RA; Prout, GR | 2 |
| Albert, J; Cantor, T; Geller, J; Geller, S; Lopez, D; Yen, S | 1 |
| Chisholm, GD; Fotherby, K; Ghanadian, R | 1 |
| De Sy, W; Vermeulen, A | 1 |
| Jacobi, GH; Wilson, JD | 1 |
| Baranowska, B; Kozłowicz, I; Migdalska, B; Szymanowski, J | 1 |
| Bartsch, G; Frick, J | 1 |
| Attramadal, A; Djoseland, O; Hansson, V; Naess, O; Weddington, SC | 1 |
| Jellinghaus, W; Schröder, FH | 1 |
| Katayama, T; Kodama, T; Shimazaki, J; Wakisaka, M | 1 |
| Altwein, JE; Hutschenreiter, G; Sinterhauf, K | 1 |
| Gurpide, E; Malathi, K | 1 |
| Bard, DR; Lasnitzki, I | 1 |
| Barowsky, NJ; Ofner, P; Singer, RM; Tashjian, AH; Vena, RL | 1 |
| Bartsch, W; Becker, H; Herzer, S; Krieg, M; Voigt, KD | 1 |
| Horton, R; Ishimaru, T; Pages, L | 1 |
| Andersson, L; Bression, D; Ekman, P; Gustafsson, JA; Högberg, B; Pousette, A; Snochowski, M | 1 |
| Chisholm, GD; Ghanadian, R; Lewis, JG; O'Donoghue, EP | 1 |
| Jacob, GH | 1 |
| Grant, JK; Sirett, DA | 2 |
| Chung, LW; Coffey, DS | 1 |
| Boesel, RW; Shain, SA | 1 |
| Bercovici, JP; Di Stefano, S; Floch, HH; Morfin, RF | 1 |
| Boileau, M; Hodges, CV; Keenan, E; Kemp, E; Lawson, R | 1 |
| Nishikawa, G | 1 |
| Clark, AF; Connolly, JG; Johnson, IE; Mobbs, BG | 1 |
| Auf, G; Chaloner, PJ; Chisholm, GD; Ghanadian, R | 1 |
| Altenähr, E; Grobe, I; Klosterhalfen, H; Krieg, M; Voight, KD | 1 |
| Albert, J; de la Vega, D; Geller, J; Loza, D; Stoeltzing, W | 1 |
| Hammond, GL; Kontturi, M; Vihko, P; Vihko, R | 1 |
| Ranft, R | 1 |
| Jacobi, GH; Moore, RJ; Wilson, JD | 1 |
| Honda, S; Kodama, T; Shimazaki, J | 1 |
| Bartsch, W; Becker, H; Krieg, M; Pinkenburg, FA | 1 |
| Bruchovsky, N; Lieskovsky, G | 1 |
| Habib, FK; Mason, MK; Smith, PH; Stitch, SR | 1 |
| Albert, J; de la Vega, D; Geller, J; Geller, S; Loza, D; Stoeltzing, W | 1 |
| Auf, G; Chisholm, GD; Ghanadian, R; O'Donoghue, EP | 1 |
| Coffey, DS; DeKlerk, DP; Ewing, LL; McDermott, IR; Reiner, WG; Robinson, CH; Scott, WW; Strandberg, JD; Talalay, P; Walsh, PC; Wheaton, LG; Zirkin, BR | 1 |
| Gazak, JM; Moore, RJ; Quebbeman, JF; Wilson, JD | 1 |
| Charles, JF; Floch, HH; Morfin, RF | 1 |
| Cook, B; Cowan, RA; Cowan, SK; Grant, JK; Sirett, DA; Wallace, AM | 1 |
| Bartsch, W; Janssen, W; Krieg, M; Voigt, KD | 1 |
| Lasnitzki, I | 1 |
| Kodama, T; Shimazaki, J | 1 |
| Albert, J; Geller, J; Lippman, S; Loza, D; Nachtsheim, D | 1 |
| Kliman, B; MacLaughlin, RA; Prout, GR | 1 |
| Bashirelahi, N; Kneussl, ES; Sanefugi, H; Trump, B; Vassil, TC; Young, JD | 1 |
| Baranowska, B; Zgliczyński, S | 1 |
| Bruchovsky, N; Callaway, T; Comeau, T; Lakey, WH; Lieskovsky, G; Rennie, P; Shnitka, T; Wilkin, P | 1 |
| Meikle, AW; Olsen, DC; Stringham, JD | 1 |
| Hakky, SI; Hall, MK; Hudson, PB; Lombardo, ME | 1 |
| Hasinski, S; Miller, JL; Rose, LI | 1 |
| Connors, K; Geller, J; Hoffman, RM; Sionit, LR | 1 |
| Fukabori, Y; Hamataki, N; Honma, S; Kushitani, M; Mieda, M; Takezawa, Y; Yamanaka, H | 1 |
| Braf, Z; Chen, J; Goldray, D; Jaccard, N; Matzkin, H; Pappas, F; Weisman, Y | 1 |
| Beisland, HO; Binkowitz, B; Brekkan, E; Ekman, P; Kontturi, M; Lehtonen, T; Lundmo, P; Pappas, F; Round, E; Shapiro, D | 1 |
| Guess, HA | 1 |
| Geller, J; Sionit, L | 1 |
| Geller, J; George, FW; McConnell, JD; Pappas, F; Stoner, E; Wilson, JD | 1 |
| Huber, GK; Kirschenbaum, A; Levine, AC; Ren, M | 1 |
| Blom, JH; Bolt-de Vries, J; de Jong, FH; Mulder, E; Reuvers, PJ; Schroeder, FH | 1 |
| Eto, S; Hara, T; Inoue, S; Izumi, M; Morimoto, I; Nagataki, S; Saito, Y | 1 |
| Buck, C; Goodman, CM; Habib, FK | 1 |
| Andriole, GL; Bracken, BR; Bruskewitz, RC; Geller, J; Gormley, GJ; Imperato-McGinley, J; McConnell, JD; Stoner, E; Tenover, JS; Walsh, PC | 1 |
| Imperato-McGinley, J; Orlic, S; Shackleton, C; Stoner, E | 1 |
| Celotti, F; Lechuga, MJ; Martini, L; Melcangi, RC; Motta, M; Negri-Cesi, P; Poletti, A; Zoppi, S | 1 |
| Chung, LW; Neubauer, BL; Petrow, V; Sikes, RA; Thomsen, S | 1 |
| French, FS; Lubahn, DB; Sar, M; Wilson, EM | 1 |
| Bogdanowicz, JF; de Jong, FH; Hayes, RB; Oishi, K; Raatgever, JW; Schroeder, FH; van der Maas, PJ; Yoshida, O | 1 |
| Lin, Y | 1 |
| Blázquez Izquierdo, J; Diego García, A; Fernández Lucas, C; Gómez Ruiz, JJ; Páez Borda, A; Prieto Chaparro, L; Rapariz González, M; Salinas Casado, J; Silmi Moyano, A; Usón Calvo, A | 1 |
| de Voogt, HJ | 1 |
| Fiorelli, G; Serio, M | 1 |
| Berman, C; Bryan, RN; Carlin, JR; Cohen, SM; Cordes, EH; Malatesta, PF; Prahalada, S; Shpungin, J; Taber, KH; Werrmann, JG | 1 |
| Bosch, RJ | 1 |
| Davies, P; Eaton, CL; Griffiths, K; Harper, ME; Peeling, B | 1 |
| Imperato-McGinley, J | 1 |
| Jenks, S | 1 |
| Tenover, JS | 1 |
| Bartsch, G; Rohr, HP; Schweikert, HU; Totzauer, P | 1 |
| Robel, P | 2 |
| Müller, RE; Traish, AM; Wotiz, HH | 1 |
| Akimoto, S; Fuse, H; Shimazaki, J | 1 |
| Johnson, MP; Murthy, LR; Rowley, DR; Scardino, PT; Tindall, DJ; Young, CY | 1 |
| Cocconi, M; Costantini, A; Martini, L; Motta, M; Natali, A; Serio, M; Zoppi, S | 1 |
| Davies, P; Kyprianou, N | 1 |
| Bashirelahi, N; Ekiko, DB; Ganesan, S; Shida, K; Takahashi, E; Yamanaka, H; Young, JD | 1 |
| Albert, J; Berry, CC; Fay, W; Geller, J; Liu, J | 1 |
| Bartsch, G; Bruengger, A; Coffey, DS; de Klerk, DP; Rohr, HP | 1 |
| Barrack, ER; Berry, SJ | 1 |
| Dunn, L; Hierowski, MT; McDonald, MW; Sullivan, JW | 1 |
| Forti, G; Giovannini, MG; Guarna, A; Magini, A; Moneti, G; Salerno, R; Serio, M | 1 |
| Kawase, M; Nakayama, R; Oishi, K; Okada, K; Sudo, K; Yoshida, O | 1 |
| Robinette, CL | 1 |
| Ogunlewe, JO; Osegbe, DN | 1 |
| Concolino, G; Conti, C; Di Silverio, F; Lubrano, C; Petrangeli, E; Sciarra, F; Toscano, V | 1 |
| Anderson, E; Farthing, MJ; Puddefoot, JR; Stebbings, WS; Vinson, GP | 1 |
| Damassa, D; Ho, SM; Kwan, PW; Leav, I; Merk, FB; Ofner, P | 1 |
| Batzold, FH; Bruchovsky, N; Fletcher, T; Goldenberg, SL; McLoughlin, MG; Rennie, PS | 1 |
| Coibion, M; Danguy, AJ; De Backer, E; de Launoit, Y; Jossa, V; Kiss, R; Paridaens, RJ; Pasteels, JL | 1 |
| Flüchter, SH; Grunwald, I; Hochstrate, H; Krieg, M; Tunn, S | 1 |
| Ishibe, T; Mizutani, M; Nakamura, K; Usui, T; Yasukawa, A | 1 |
| Costantini, A; Fiorelli, G; Forti, G; Marinoni, T; Martini, L; Moneti, G; Natali, A; Salerno, R; Serio, M; Zoppi, S | 1 |
| Lasnitzki, I; Mizuno, T; Takeda, H | 1 |
| Costantini, A; De Bellis, A; Fiorelli, G; Longo, A; Natali, A; Serio, M | 1 |
| Bruun, E; Frandsen, H; Frimodt-Møller, C; Nielsen, K; Rasmussen, LB; Vinnergaard, T | 1 |
| Barbolt, TA; Batzold, FH; Juniewicz, PE; LaBrie, TK; Lemp, BM; Reel, JR | 1 |
| Coune, A; Nijs, M | 1 |
| Tohjoh, S | 1 |
| Abalain, JH; Amet, Y; Carre, JL; Floch, HH; Mangin, P; Quemener, E; Simon, B | 1 |
| Bongini, M; Bozzolan, F; Doukani, A; Mauvais-Jarvis, P; Poizat, R; Wright, F | 1 |
| Griffiths, K; Harper, ME; Syms, AJ | 1 |
| Ahmed, K; Goueli, SA; Lange, P; Rayan, A | 1 |
| Albert, J; Geller, J; Kirshner, M; Liu, J | 1 |
| McMahon, MJ; Thomas, GH | 1 |
| Griffiths, K; Harper, ME; Peeling, WB; Pierrepoint, CG; Pike, A | 1 |
| Giorgi, EP; Grant, JK; Scott, R; Stewart, JC | 1 |
| Farnsworth, WE | 1 |
| Giorgi, EP; Grant, JK; Shirley, IM; Stewart, JC | 1 |
| Hollmann, HJ; Schmidt, H; Steins, P; Voigt, KD | 1 |
| Becker, H; Klosterhalfen, H; Voigt, KD | 1 |
| Ban, RW; Cooper, JF; Foti, A; Imfeld, H | 1 |
| Griffiths, K; Harper, ME; Peeling, WB; Pike, A | 1 |
| Belis, JA; Dieringer, CS; Dombrosky, JT; Lloyd, JW; Mawhinney, MG; Schwartz, FL; Thomas, JA | 1 |
| Becker, H; Horst, HJ; Voigt, KD | 1 |
| Lloyd, JW; Mawhinney, MG; Schwartz, FL; Thomas, JA | 1 |
| Anderson, CK; Fraser, HM; Mitchell, AJ; Oakey, RE | 1 |
| Hollmann, HJ; Krieg, M; Steins, P; Voigt, KD | 1 |
| Altwein, JE; Klose, K; Knapstein, P; Orestano, F; Rubin, A | 1 |
| Antonipillai, I; Murphy, BE; Tan, SY | 1 |
| Bricaire, H; Delassalle, A; Mahoudeau, JA | 1 |
| Butler, AV; McMahon, MJ; Thomas, GH | 1 |
| Tveter, KJ | 1 |
| Falkanger, B; Harbitz, TB; Sander, S | 1 |
| Ito, Y; Kurihara, H; Shida, K; Shimazaki, J | 1 |
| Siiteri, PK; Wilson, JD | 1 |
| Gloyna, RE; Siiteri, PK; Wilson, JD | 1 |
56 review(s) available for dihydrotestosterone and Adenoma, Prostatic
| Article | Year |
|---|---|
Treatment of Benign Prostatic Hyperplasia by Natural Drugs.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Biological Products; Dihydrotestosterone; Estrogens; Humans; Male; Phytotherapy; Plant Extracts; Plants, Medicinal; Prostatic Hyperplasia; Serenoa; Testosterone | 2021 |
Prostate cancer prevention with 5-alpha reductase inhibitors: concepts and controversies.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Dihydrotestosterone; Dutasteride; Early Detection of Cancer; Finasteride; Humans; Male; Organ Size; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Receptors, Androgen; Risk Factors | 2018 |
5α-Reductase Inhibitors (5ARIs) and Male Reproduction.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Dihydrotestosterone; Humans; Libido; Male; Penile Erection; Prostatic Hyperplasia; Sperm Count; Sperm Motility | 2017 |
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aging; Diabetes Mellitus; Dihydrotestosterone; Dutasteride; Dyslipidemias; Finasteride; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Prostatic Hyperplasia; Receptors, Androgen | 2019 |
Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Androgens; Dihydrotestosterone; Drug Discovery; Humans; Male; Molecular Conformation; Prostatic Hyperplasia; Prostatic Neoplasms; Structure-Activity Relationship | 2016 |
[Influence of dihydrotestosterone deficit on treatment of prostatic diseases regarding to contemporary methods of prostatic hypertrophy treatments].
Topics: Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Humans; Male; Oxidoreductases; Prostatic Diseases; Prostatic Hyperplasia | 2008 |
A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aging; Azasteroids; Dihydrotestosterone; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Testosterone; Urinary Tract Infections | 2009 |
Benign prostatic hyperplasia: current clinical practice.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Cholinergic Antagonists; Dihydrotestosterone; Disease Progression; Humans; Male; Primary Health Care; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Testosterone; Watchful Waiting | 2010 |
The role of non-aromatizable testosterone metabolite in metabolic pathways.
Topics: Adipose Tissue; Alopecia; Androgens; Animals; Body Composition; Cardiovascular Diseases; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Male; Mice; Obesity; Prostatic Hyperplasia; Rats; Receptors, Androgen; Testosterone | 2011 |
Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
Topics: Adult; Dihydrotestosterone; Humans; Immunoassay; Male; Mass Spectrometry; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 2012 |
Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Contraindications; Dihydrotestosterone; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 2012 |
[Dihydrotestosterone and the role of 5 alpha-reductase inhibitors in benign prostatic hyperplasia].
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adult; Aged; Azasteroids; Clinical Trials as Topic; Dihydrotestosterone; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Isoenzymes; Male; Middle Aged; Prostate; Prostatic Hyperplasia | 2002 |
[Hormonal therapy for benign prostatic hyperplasia].
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Azasteroids; Depression, Chemical; Dihydrotestosterone; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testosterone; Treatment Outcome | 2002 |
Molecular and cellular prostate biology: origin of prostate-specific antigen expression and implications for benign prostatic hyperplasia.
Topics: Dihydrotestosterone; Endocrine System; Epithelial Cells; Gene Expression; Humans; Male; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia | 2004 |
Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Azasteroids; Clinical Trials as Topic; Dihydrotestosterone; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder Neck Obstruction | 2004 |
[5alpha-dihydrotestosterone (DHT)].
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Biomarkers; Diagnostic Techniques, Endocrine; Dihydrotestosterone; Enzyme Inhibitors; Female; Feminization; Finasteride; Humans; Isoenzymes; Male; Prostatic Hyperplasia; Radioimmunoassay; Receptors, Androgen | 2005 |
Use of 5alpha-reductase inhibitors to prevent benign prostatic hyperplasia disease.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Biomarkers; Dihydrotestosterone; Disease Progression; Enzyme Inhibitors; Humans; Male; Prostate-Specific Antigen; Prostatic Hyperplasia; Quality of Life; United States; Urinary Retention | 2006 |
Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Dihydrotestosterone; Disease Progression; Humans; Male; Prostatic Hyperplasia; Prostatism; Risk Factors; Treatment Outcome | 2007 |
Prostate tissue androgens: history and current clinical relevance.
Topics: Biopsy; Dihydrotestosterone; Hormone Replacement Therapy; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 2008 |
The pathogenesis of benign prostatic hyperplasia.
Topics: Adolescent; Adult; Aged; Aging; Androgens; Androstanols; Animals; Castration; Child; Dihydrotestosterone; Disease Models, Animal; Estradiol; Estrogens; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Species Specificity; Testicular Hormones | 1980 |
Regulation of prostate growth in organ culture.
Topics: Animals; Cell Differentiation; Cell Division; Culture Media; Dihydrotestosterone; Dogs; Hormones; Humans; Male; Mice; Neoplasms, Experimental; Organ Culture Techniques; Polyamines; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Testosterone; Vitamin A | 1980 |
Control of prostate growth.
Topics: Adrenal Glands; Adult; Aged; Dihydrotestosterone; Estradiol; Estrone; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Gland; Progesterone-Binding Globulin; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testis; Testosterone; Transcortin | 1981 |
Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyperplastic, and neoplastic canine prostate.
Topics: Androstane-3,17-diol; Animals; Binding, Competitive; Carbohydrates; Castration; Cell Differentiation; Dihydrotestosterone; Dog Diseases; Dogs; Epithelium; Estradiol; Histocytochemistry; Male; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Mitogen | 1984 |
Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.
Topics: Aging; Animals; Dihydrotestosterone; Dogs; Estrogens; Gonadal Steroid Hormones; Humans; In Vitro Techniques; Kinetics; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testosterone | 1984 |
Human benign prostatic hyperplasia: etiological considerations.
Topics: Age Factors; Androgens; Animals; Dihydrotestosterone; Drug Synergism; Estrogens; Humans; Male; Organ Size; Prostate; Prostatic Hyperplasia; Testis | 1984 |
Pathology of BPH.
Topics: Adult; Aged; Aged, 80 and over; Animals; Biomarkers; Connective Tissue; Dihydrotestosterone; Epidermal Growth Factor; Epithelium; Fibroblast Growth Factors; Humans; Male; Middle Aged; Prevalence; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Rodentia; Transforming Growth Factor beta | 1993 |
[Newly approved specialty drugs in Austria and new knowledge about already available specialty drugs. Proscar film tablets (Finasterid, MSD)].
Topics: 5-alpha Reductase Inhibitors; Austria; Clinical Trials as Topic; Dihydrotestosterone; Drug Approval; Finasteride; Humans; Male; Prostatic Hyperplasia; Tablets | 1994 |
[Drug therapy for prostatic hyperplasia].
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Androgens; Dihydrotestosterone; Finasteride; Humans; Male; Prostatic Hyperplasia | 1993 |
[Etiopathogenesis of benign prostatic hypertrophy].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Androgens; Animals; Dihydrotestosterone; Dogs; Estrogens; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Stem Cells | 1995 |
Benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aging; Dihydrotestosterone; Finasteride; Humans; Male; Prostate; Prostatectomy; Prostatic Hyperplasia; Urodynamics | 1995 |
Prostatic growth: new insights into hormonal regulation.
Topics: Androgens; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Isoenzymes; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testosterone | 1995 |
Transdermal dihydrotestosterone treatment of 'andropause'.
Topics: Administration, Cutaneous; Aged; Aging; Cardiovascular Diseases; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Testosterone | 1993 |
Role of dihydrotestosterone in androgen action.
Topics: Androgens; Animals; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Male; Oxidoreductases; Prostatic Hyperplasia | 1996 |
Oxytocin and prostatic function.
Topics: Aging; Animals; Dihydrotestosterone; Dogs; Humans; Male; Oxytocin; Prostate; Prostatic Hyperplasia; Rats; Testis | 1995 |
Benign prostatic hyperplasia: natural history, endocrine pathogenesis, and medical treatment with finasteride.
Topics: Adolescent; Adult; Aged; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Risk Factors; Urination Disorders | 1996 |
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aging; Clinical Trials as Topic; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prognosis; Prostatic Hyperplasia; Sensitivity and Specificity | 2000 |
5alpha-reductase activity in the prostate.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Animals; Cryptorchidism; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Forecasting; Humans; Infertility, Male; Isoenzymes; Male; Mice; Mice, Knockout; Mutation; Penile Erection; Penis; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Testis; Tumor Cells, Cultured | 2001 |
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Administration, Oral; Aged; Aging; Azasteroids; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Administration Schedule; Dutasteride; Finasteride; Humans; Male; Middle Aged; Multicenter Studies as Topic; Probability; Prognosis; Prostatic Hyperplasia; Treatment Outcome | 2002 |
Androgen binding and metabolism in the human prostate.
Topics: Androgens; Androstanes; Androstenedione; Animals; Cytosol; Dihydrotestosterone; Humans; Male; Muscles; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Binding; Rats; Receptors, Cell Surface; Testosterone | 1975 |
Androgen metabolism in patients with benign prostatic hypertrophy.
Topics: Adult; Aged; Aging; Androgens; Androstane-3,17-diol; Androstanes; Androstenedione; Androsterone; Animals; Blood Proteins; Cyproterone; Dihydrotestosterone; Estradiol; Estrogens; Female; Humans; Male; Middle Aged; Muscles; Progestins; Prostate; Prostatic Hyperplasia; Protein Binding; Testosterone | 1975 |
Finasteride for benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Androstenes; Azasteroids; Dihydrotestosterone; Finasteride; Humans; Male; Prostatic Hyperplasia | 1992 |
Benign prostatic hyperplasia: antecedents and natural history.
Topics: Adult; Aged; Dihydrotestosterone; Estrogens; Growth Substances; Humans; Male; Middle Aged; Prevalence; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Adrenergic; Risk Factors; Testosterone | 1992 |
Benign prostatic hyperplasia: new insights.
Topics: Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Testosterone | 1992 |
Androgen metabolism in different target tissues.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aging; Androstenedione; Animals; Brain; Cricetinae; Dihydrotestosterone; Humans; Male; Pituitary Gland; Prostate; Prostatic Hyperplasia; Rats; Testosterone | 1990 |
[Benign hypertrophy of the prostate: pathogenic aspects].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cause of Death; Dihydrotestosterone; Humans; Incidence; Male; Middle Aged; Prostatic Hyperplasia; Retrospective Studies | 1991 |
Biology of the prostate.
Topics: Animals; Dihydrotestosterone; Estrogens; Humans; Male; Prostate; Prostatic Hyperplasia; Reference Values | 1991 |
Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Androgens; Androstenes; Azasteroids; Carcinoma; Cell Division; Cells, Cultured; Dihydrotestosterone; Epidermal Growth Factor; Finasteride; Gonadotropin-Releasing Hormone; Growth Substances; Humans; Insulin-Like Growth Factor I; Male; Peptides; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Tumor Cells, Cultured | 1991 |
Benign prostatic hyperplasia: pathogenesis and medical therapy.
Topics: Adrenergic alpha-Antagonists; Aging; Dihydrotestosterone; Estrogens; Humans; Male; Prostatic Hyperplasia; Testosterone | 1991 |
Pathogenesis of benign prostatic hyperplasia.
Topics: Androgens; Dihydrotestosterone; Embryonic Induction; Estrogens; Humans; Male; Prostate; Prostatic Hyperplasia; Stem Cells | 1991 |
Steroid hormones and the pathogenesis of benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aging; Androgens; Animals; Dihydrotestosterone; Dogs; Estrogens; Growth Substances; Humans; Male; Prostate; Prostatic Hyperplasia | 1991 |
Prostates, pates, and pimples. The potential medical uses of steroid 5 alpha-reductase inhibitors.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Animals; Dihydrotestosterone; Hair Diseases; Humans; Male; Prostatic Hyperplasia; Skin Diseases | 1991 |
[Steroid substances--androgens].
Topics: Androgens; Animals; Cell Division; Dihydrotestosterone; DNA; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testis; Testosterone | 1986 |
Overview of benign prostatic hypertrophy.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androgen Antagonists; Castration; Dihydrotestosterone; Estrogens; Gonadotropin-Releasing Hormone; Humans; Male; Prostatic Hyperplasia; Testis | 1989 |
Pathogenesis and medical treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Androgen Antagonists; Dihydrotestosterone; Estrogen Antagonists; Humans; Male; Orchiectomy; Prostate; Prostatic Hyperplasia | 1989 |
Recent studies on the mechanism of action of testosterone.
Topics: Androgen-Insensitivity Syndrome; Androgens; Animals; Binding Sites; Cell Membrane; Cell Nucleus; Dihydrotestosterone; Disorders of Sex Development; Dogs; Endoplasmic Reticulum; Genitalia, Male; Growth; Humans; Male; Prostate; Prostatic Hyperplasia; Protein Binding; Rats; Skin; Testosterone | 1972 |
Some aspects of the pathogenesis of prostatic hyperplasia.
Topics: Adrenocorticotropic Hormone; Animals; Dehydroepiandrosterone; Dihydrotestosterone; Estrogens; Female; Globulins; Humans; Male; Mice; Pituitary Gland; Pregnancy; Progesterone; Prolactin; Prostate; Prostatic Hyperplasia; Rats; Receptors, Cell Surface; Stimulation, Chemical; Testosterone; Tritium | 1974 |
38 trial(s) available for dihydrotestosterone and Adenoma, Prostatic
| Article | Year |
|---|---|
Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Ageratum; Anti-Inflammatory Agents; Biomarkers; Blood Glucose; Cell Line; Cholestenone 5 alpha-Reductase; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Estradiol; Humans; Hydrocortisone; Kallikreins; Male; Middle Aged; Plant Extracts; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Urination | 2017 |
Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Azasteroids; Dihydrotestosterone; Dose-Response Relationship, Drug; Double-Blind Method; Dutasteride; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Longitudinal Studies; Lower Urinary Tract Symptoms; Male; Middle Aged; Organ Size; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Testosterone; Treatment Outcome | 2015 |
Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction.
Topics: 5-alpha Reductase Inhibitors; Dihydrotestosterone; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Organ Size; Prospective Studies; Prostate; Prostatic Hyperplasia; Testosterone | 2016 |
Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
Topics: Aged; Azasteroids; Dihydrotestosterone; Dutasteride; Enzyme Inhibitors; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Time Factors | 2008 |
Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot study.
Topics: 5-alpha Reductase Inhibitors; Antigens, Neoplasm; Azasteroids; Biomarkers, Tumor; Dihydrotestosterone; Dose-Response Relationship, Drug; Dutasteride; Enzyme Inhibitors; Humans; Longitudinal Studies; Male; Middle Aged; Pilot Projects; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone | 2009 |
Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
Topics: Administration, Cutaneous; Androgens; Antigens, Neoplasm; Body Composition; Bone Density; Collagen Type I; Dihydrotestosterone; Double-Blind Method; Estradiol; Fetal Proteins; Gels; Humans; Luteinizing Hormone; Male; Middle Aged; Peptide Fragments; Procollagen; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Testosterone; Ultrasonography | 2010 |
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Aged; Azasteroids; Dihydrotestosterone; Double-Blind Method; Drug Administration Schedule; Dutasteride; Follow-Up Studies; Humans; Male; Otorhinolaryngologic Diseases; Placebos; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Treatment Outcome | 2002 |
Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism.
Topics: Aged; Androgen Antagonists; Cell Nucleus; Chromatin; Dihydrotestosterone; DNA; Double-Blind Method; Epithelial Cells; Humans; Karyometry; Male; Middle Aged; Placebos; Plant Extracts; Prostate; Prostatic Hyperplasia; ROC Curve; Serenoa; Treatment Outcome | 2002 |
Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
Topics: Androgen Antagonists; Androgens; Azasteroids; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Dose-Response Relationship, Drug; Dutasteride; Enzyme Inhibitors; Humans; Luteinizing Hormone; Male; Middle Aged; Osmolar Concentration; Prostatic Hyperplasia; Testosterone | 2004 |
Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma.
Topics: Adult; Cabergoline; Case-Control Studies; Dihydrotestosterone; Dopamine Agonists; Ergolines; Humans; Male; Middle Aged; Pilot Projects; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Prostate; Prostatic Hyperplasia; Testosterone; Ultrasonography | 2004 |
Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Azasteroids; Dihydrotestosterone; Double-Blind Method; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Gynecomastia; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia | 2004 |
[Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia].
Topics: Aged; Azasteroids; Dihydrotestosterone; Double-Blind Method; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Prospective Studies; Prostatic Hyperplasia | 2005 |
Efficacy and tolerability of the dual 5alpha-reductase inhibitor, dutasteride, in the treatment of benign prostatic hyperplasia in African-American men.
Topics: 5-alpha Reductase Inhibitors; Acute Disease; Aged; Aged, 80 and over; Azasteroids; Biomarkers; Black or African American; Dihydrotestosterone; Double-Blind Method; Dutasteride; Enzyme Inhibitors; Humans; Linear Models; Male; Middle Aged; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Hyperplasia; Severity of Illness Index; Testosterone; Treatment Outcome; Urinary Retention; Urination; Urodynamics; Urologic Surgical Procedures, Male; White People | 2006 |
The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
Topics: Aged; Azasteroids; Dihydrotestosterone; Double-Blind Method; Dutasteride; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Testosterone | 2007 |
Finasteride for the treatment and control of benign prostatic hyperplasia: summary of phase III controlled studies. The Finasteride Study Group.
Topics: Aged; Dihydrotestosterone; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia | 1994 |
Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia.
Topics: Adult; Aged; Aged, 80 and over; Dihydrotestosterone; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Severity of Illness Index; Urodynamics | 1994 |
Clinical results with finasteride.
Topics: Biomarkers; Dihydrotestosterone; Double-Blind Method; Finasteride; Follow-Up Studies; Humans; Male; North America; Placebos; Prostate; Prostatic Hyperplasia; Time Factors; Urodynamics | 1994 |
A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia.
Topics: Adult; Aged; Alcohol Drinking; Androstenedione; Blood Pressure; Case-Control Studies; Dihydrotestosterone; Estradiol; Estrone; Exercise; Humans; Male; Middle Aged; Odds Ratio; Prospective Studies; Prostatic Hyperplasia; Testosterone | 1995 |
Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia.
Topics: Aged; Androgen Antagonists; Androstenedione; Anilides; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Nitriles; Prolactin; Prostatic Hyperplasia; Testosterone; Tosyl Compounds | 1995 |
Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Androstenes; Azasteroids; Dihydrotestosterone; Double-Blind Method; Drug Tolerance; Finasteride; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Testosterone; Ultrasonography; Urination | 1993 |
Long-term urodynamic effects of finasteride in benign prostatic hyperplasia: a pilot study.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Androstenes; Azasteroids; Dihydrotestosterone; Dose-Response Relationship, Drug; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Pilot Projects; Prostate-Specific Antigen; Prostatic Hyperplasia; Time Factors; Urodynamics | 1993 |
Androgen metabolism in men receiving finasteride before prostatectomy.
Topics: Androstane-3,17-diol; Combined Modality Therapy; Dihydrotestosterone; Double-Blind Method; Finasteride; Humans; Male; Preoperative Care; Prostate; Prostatectomy; Prostatic Hyperplasia; Testosterone | 1993 |
Evidence for atrophy and apoptosis in the prostates of men given finasteride.
Topics: 5-alpha Reductase Inhibitors; Apoptosis; Atrophy; Dihydrotestosterone; DNA; Double-Blind Method; Enzyme Inhibitors; Epithelium; Finasteride; Humans; Male; Placebos; Prostate; Prostatic Hyperplasia; Transglutaminases | 1996 |
The concentrations of the endogenous C19-steroids in hyperplastic prostatic tissue and the effect of finasteride treatment.
Topics: 5-alpha Reductase Inhibitors; Aged; Androstenedione; Dihydrotestosterone; Enzyme Inhibitors; Epitestosterone; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Steroids; Testosterone | 1996 |
Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Androgens; Androstenedione; Dihydrotestosterone; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Testosterone | 1997 |
Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia.
Topics: Aged; Dihydrotestosterone; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Hyperplasia; Remission Induction; Ultrasonography | 1997 |
Effects of the 5 alpha-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Aldosterone; Androgens; Dehydroepiandrosterone; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Hydrocortisone; Luteinizing Hormone; Male; Middle Aged; Pregnenediones; Prospective Studies; Prostatic Hyperplasia; Testosterone | 1998 |
Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH).
Topics: Aged; Body Composition; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Humans; Lipoproteins; Male; Middle Aged; Oxidoreductases; Prostatic Hyperplasia | 1999 |
Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy.
Topics: Animals; Dihydrotestosterone; Dog Diseases; Dogs; Double-Blind Method; Finasteride; Male; Prostate; Prostatic Hyperplasia; Radiography; Semen; Testosterone; Ultrasonography | 2001 |
Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
Topics: Aged; Androgen Antagonists; Biopsy, Needle; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Placebos; Plant Extracts; Prostate; Prostatic Hyperplasia; Serenoa; Testosterone; Treatment Outcome | 2001 |
Prolonged treatment with finasteride (a 5 alpha-reductase inhibitor) does not affect bone density and metabolism.
Topics: 5-alpha Reductase Inhibitors; Absorptiometry, Photon; Aged; Androstenes; Azasteroids; Bone and Bones; Bone Density; Calcitriol; Calcium; Dihydrotestosterone; Double-Blind Method; Drug Administration Schedule; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia | 1992 |
Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Aged, 80 and over; Androstenes; Azasteroids; Dihydrotestosterone; Double-Blind Method; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Osteocalcin; Prostate-Specific Antigen; Prostatic Hyperplasia; Scandinavian and Nordic Countries; Testosterone; Urination | 1992 |
Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride.
Topics: 5-alpha Reductase Inhibitors; Androstenes; Azasteroids; Dihydrotestosterone; Finasteride; Humans; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1992 |
Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Aged; Androstenes; Azasteroids; Dihydrotestosterone; Dose-Response Relationship, Drug; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Testosterone | 1992 |
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Androstenes; Azasteroids; Dihydrotestosterone; Double-Blind Method; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Urodynamics | 1992 |
C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Androstenedione; Androstenes; Androsterone; Azasteroids; Corticosterone; Dihydrotestosterone; Disorders of Sex Development; Etiocholanolone; Finasteride; Gas Chromatography-Mass Spectrometry; Humans; Hydrocortisone; Liver; Luteinizing Hormone; Male; Middle Aged; Prostatic Hyperplasia; Radioimmunoassay; Randomized Controlled Trials as Topic; Steroids, Heterocyclic; Testosterone | 1990 |
5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Androstenes; Azasteroids; Dihydrotestosterone; Disorders of Sex Development; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia | 1991 |
Effects of two different medical treatments on dihydrotestosterone content and androgen receptors in human benign prostatic hyperplasia.
Topics: Androgen Antagonists; Anilides; Cell Nucleus; Cyproterone; Cyproterone Acetate; Cytosol; Dihydrotestosterone; Flutamide; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Tamoxifen | 1988 |
417 other study(ies) available for dihydrotestosterone and Adenoma, Prostatic
| Article | Year |
|---|---|
5-Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Atrophy; Dihydrotestosterone; Humans; Lower Urinary Tract Symptoms; Male; Prostate; Prostatic Hyperplasia | 2022 |
Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Berberine; Dihydrotestosterone; Disease Models, Animal; Drugs, Chinese Herbal; Finasteride; Interleukin-1beta; Male; Oxidative Stress; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Testosterone; Tumor Necrosis Factor-alpha | 2021 |
Photothermal therapeutic potency of plasmonic silver nanoparticles for apoptosis and anti-angiogenesis in testosterone induced benign prostate hyperplasia in rats.
Topics: Animals; Antioxidants; Apoptosis; Dihydrotestosterone; Drug Delivery Systems; Finasteride; Hyperplasia; Male; Metal Nanoparticles; Neovascularization, Pathologic; Phototherapy; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Silver; Surface Plasmon Resonance; Testosterone; Testosterone Propionate | 2022 |
Purple Corn Extract Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
Topics: Animals; Anthocyanins; Apoptosis; Cell Proliferation; Dihydrotestosterone; Humans; Male; Phosphatidylinositol 3-Kinases; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Testosterone; Testosterone Propionate; Zea mays | 2022 |
Naftopidil enantiomers suppress androgen accumulation and induce cell apoptosis via the UDP-glucuronosyltransferase 2B15 in benign prostate hyperplasia.
Topics: Androgens; Animals; Apoptosis; Dihydrotestosterone; Glucuronosyltransferase; Humans; Hyperplasia; Male; Naphthalenes; Piperazines; Prostate; Prostatic Hyperplasia; Rats; Receptors, Androgen; Uridine Diphosphate | 2022 |
Comparative application of testosterone undecanoate and/or testosterone propionate in induction of benign prostatic hyperplasia in Wistar rats.
Topics: Animals; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Rats; Rats, Wistar; Reproducibility of Results; Testosterone; Testosterone Propionate | 2022 |
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Dihydrotestosterone; Glucocorticoids; Humans; Hyperplasia; Lower Urinary Tract Symptoms; Male; Membrane Proteins; Prostate; Prostatic Hyperplasia | 2022 |
Inhibitory effects of
Topics: Animals; Centella; Corn Oil; Dihydrotestosterone; Finasteride; Humans; Male; Phosphatidylinositol 3-Kinases; Plant Extracts; Prostate; Prostatic Hyperplasia; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Signal Transduction; Testosterone; Testosterone Propionate; Triterpenes | 2022 |
Effects of Alginate Oligosaccharide on Testosterone-Induced Benign Prostatic Hyperplasia in Orchiectomized Rats.
Topics: Aged; Alginates; Androgens; Animals; Dihydrotestosterone; Humans; Male; Plant Extracts; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Testosterone | 2023 |
Topics: Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Testosterone | 2023 |
Tomato lipidic extract plus selenium decrease prostatic hyperplasia, dihydrotestosterone and androgen receptor expression versus finasteride in rats.
Topics: Androgens; Animals; Antioxidants; Dihydrotestosterone; Finasteride; Male; Prostatic Hyperplasia; Rats; Rats, Wistar; Receptors, Androgen; Selenium; Solanum lycopersicum; Testosterone | 2023 |
Diacerein provokes apoptosis, improves redox balance, and downregulates PCNA and TNF-α in a rat model of testosterone-induced benign prostatic hyperplasia: A new non-invasive approach.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Dihydrotestosterone; Male; Oxidation-Reduction; Plant Extracts; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Testosterone; Tumor Necrosis Factor-alpha | 2023 |
Changes in specific serum biomarkers during the induction of prostatic hyperplasia in dogs.
Topics: Animals; Biomarkers; Dihydrotestosterone; Dog Diseases; Dogs; Esterases; Estrogens; Male; Prostate-Specific Antigen; Prostatic Hyperplasia; Testosterone | 2019 |
The therapeutic effects of Stauntonia hexaphylla in benign prostate hyperplasia are mediated by the regulation of androgen receptors and 5α-reductase type 2.
Topics: Animals; Cell Line; Cell Survival; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Male; Plant Extracts; Prostate; Prostatic Hyperplasia; Ranunculales; Rats, Sprague-Dawley; Receptors, Androgen | 2020 |
Rhodesian Ridgebacks have an increased risk to develop benign prostatic hyperplasia.
Topics: Animals; Carboxylic Ester Hydrolases; Dihydrotestosterone; Dog Diseases; Dogs; Estradiol; Hemospermia; Male; Prostate; Prostatic Hyperplasia; Semen Analysis; Species Specificity; Testosterone; Ultrasonography | 2020 |
Mangosteen pericarp components alleviate progression of prostatic hyperplasia and mitochondrial dysfunction in rats.
Topics: Animals; Body Weight; Diet, High-Fat; Dietary Supplements; Dihydrotestosterone; Disease Models, Animal; Disease Progression; Garcinia mangostana; Male; Malondialdehyde; Mitochondria; Nitric Oxide Synthase Type II; Oxidative Stress; Plant Extracts; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred F344; Testosterone | 2020 |
Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Animals; Apoptosis; Cell Line; Cell Proliferation; Dihydrotestosterone; Disease Models, Animal; Enzyme Inhibitors; Flavonoids; Humans; Male; Proliferating Cell Nuclear Antigen; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Proto-Oncogene Proteins c-bcl-2; Rats; Receptors, Androgen; Testosterone | 2020 |
Changes in the Serum Prostatic Biomarkers During the Treatment of Benign Prostatic Hyperplasia with a 5alpha-reductase Inhibitor: Finasteride.
Topics: 5-alpha Reductase Inhibitors; Acid Phosphatase; Animals; Biomarkers; Dihydrotestosterone; Dog Diseases; Dogs; Esterases; Estradiol; Finasteride; Male; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Testosterone; Ultrasonography | 2020 |
Novel and Predictive QSAR Model for Steroidal and Nonsteroidal 5α- Reductase Type II Inhibitors.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Dihydrotestosterone; Drug Discovery; gamma-Tocopherol; Humans; Isoenzymes; Male; Membrane Proteins; Plant Preparations; Prostatic Hyperplasia; Quantitative Structure-Activity Relationship | 2021 |
Simultaneous quantification of oestrogens and androgens in the serum of patients with benign prostatic hyperplasia by liquid chromatography-Tandem mass spectrometry.
Topics: Aged; Androgens; Androstenedione; Chromatography, Liquid; Dihydrotestosterone; Estrogens; Humans; Male; Prostatic Hyperplasia; Tandem Mass Spectrometry; Testosterone | 2020 |
Perfusion change in benign prostatic hyperplasia before and after castration in a canine model: Contrast enhanced ultrasonography and CT perfusion study.
Topics: Animals; Dihydrotestosterone; Dog Diseases; Dogs; Male; Perfusion; Prostatic Hyperplasia; Testosterone; Tomography, X-Ray Computed; Ultrasonography | 2020 |
Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs.
Topics: Animals; Dihydrotestosterone; Dog Diseases; Dogs; Estrogens; Finasteride; Hormones; Male; Prostatic Hyperplasia; Reproduction; Spermatozoa; Testosterone | 2020 |
Cranberry Powder Attenuates Benign Prostatic Hyperplasia in Rats.
Topics: Animals; Biomarkers; Dihydrotestosterone; Fruit; Male; Plant Preparations; Powders; Prostatic Hyperplasia; Random Allocation; Rats; Rats, Sprague-Dawley; Vaccinium macrocarpon | 2020 |
Endocrine, prostatic vascular, and proapoptotic changes in dogs with benign prostatic hyperplasia treated medically or surgically.
Topics: Animals; Dihydrotestosterone; Dog Diseases; Dogs; Finasteride; Male; Prostate; Prostatic Hyperplasia; Testosterone | 2021 |
Topics: Amino Acids; Animals; Cells, Cultured; Cordyceps; Culture Media, Conditioned; Dihydrotestosterone; Eunuchism; Fruiting Bodies, Fungal; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Sugars; Testis; Testosterone; Trehalose | 2020 |
Psoralea corylifolia L. extract ameliorates benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis.
Topics: Animals; Apoptosis; Cell Line; Cell Proliferation; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Disease Models, Animal; Drugs, Chinese Herbal; Humans; Male; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Hyperplasia; Psoralea; Rats, Wistar; Receptors, Androgen; Testosterone Propionate | 2021 |
GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition.
Topics: Animals; Cell Line; Cell Proliferation; Dihydrotestosterone; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Prostatic Hyperplasia; Receptors, Androgen; Telomerase | 2021 |
Yohimbine hydrochloride inhibits benign prostatic hyperplasia by downregulating steroid 5α-reductase type 2.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Dihydrotestosterone; Finasteride; Male; Prostatic Hyperplasia; Rats; Yohimbine | 2021 |
Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
Topics: Aged; Androgens; Biopsy; Chromatography, Liquid; Dihydrotestosterone; Humans; Male; Middle Aged; Organ Size; Prostate; Prostatic Hyperplasia; Statistics as Topic; Testosterone | 2017 |
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Amides; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Dihydrotestosterone; Dinoprostone; Disease Models, Animal; Drug Combinations; Drug Compounding; Ethanolamines; Glucosides; Inflammation Mediators; Male; Oxidative Stress; Palmitic Acids; Prostate; Prostatic Hyperplasia; Rats, Sprague-Dawley; Signal Transduction; Stilbenes; Testosterone Propionate | 2017 |
Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.
Topics: Animals; Antioxidants; Catalase; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Disease Models, Animal; Fruit; Glutathione Peroxidase; Glutathione Reductase; Male; Organ Size; Phytotherapy; Plant Extracts; Poncirus; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Rats, Sprague-Dawley; Superoxide Dismutase; Testosterone; Testosterone Propionate | 2017 |
In vivo evaluation of hot water extract of Acorus gramineus root against benign prostatic hyperplasia.
Topics: Acorus; Animals; Antioxidants; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Gene Expression Profiling; Male; Organ Size; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Receptors, Androgen | 2017 |
Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).
Topics: Aged; Androstenediol; Body Mass Index; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Estrone; Gas Chromatography-Mass Spectrometry; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Prospective Studies; Prostate; Prostatic Hyperplasia; Testosterone; Urinary Bladder Neoplasms | 2017 |
Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α-reductase 2.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aromatase; Boston; Cells, Cultured; Dihydrotestosterone; DNA Methylation; Epigenesis, Genetic; Estradiol; Estrogen Receptor alpha; Gene Expression Regulation, Enzymologic; Humans; Male; Membrane Proteins; Phosphorylation; Promoter Regions, Genetic; Prostate; Prostatic Hyperplasia; RNA Interference; Signal Transduction; Stromal Cells; Testosterone; Texas; Transfection; Tumor Necrosis Factor-alpha | 2017 |
Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
Topics: Animals; Apoptosis; Cell Proliferation; Combretaceae; Dihydrotestosterone; Humans; Male; Plant Extracts; Proliferating Cell Nuclear Antigen; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Seeds; Testosterone; Testosterone Propionate | 2017 |
NAD(P)H-quinone oxidoreductase 1 silencing aggravates hormone-induced prostatic hyperplasia in mice.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Cell Line, Tumor; Dihydrotestosterone; HSP90 Heat-Shock Proteins; Humans; Male; Mice; Mice, Knockout; NAD(P)H Dehydrogenase (Quinone); Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testosterone; Testosterone Propionate | 2018 |
Finasteride accelerates prostate wound healing after thulium laser resection through DHT and AR signalling.
Topics: Animals; Cell Line; Cell Movement; Cell Proliferation; Dihydrotestosterone; Dogs; Down-Regulation; Drug Evaluation, Preclinical; Epithelium; Finasteride; Humans; Laser Therapy; Male; Prostate; Prostatic Hyperplasia; Proto-Oncogene Proteins c-myc; Receptors, Androgen; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Testosterone; Tumor Necrosis Factor-alpha; Wound Healing | 2018 |
Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Proliferation; Cell Survival; Cyclin D1; Cyclooxygenase 2; Dihydrotestosterone; Dinoprostone; Glutathione Reductase; Humans; Male; Malondialdehyde; Medicine, Traditional; Oxidative Stress; Phytotherapy; Plant Extracts; Proliferating Cell Nuclear Antigen; Prostatic Hyperplasia; Rats, Sprague-Dawley; Reactive Oxygen Species | 2018 |
Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).
Topics: Ajuga; Animals; Apoptosis; Cholestenone 5 alpha-Reductase; Cyclooxygenase 2; Dihydrotestosterone; Dinoprostone; Disease Models, Animal; Epilobium; Male; Malondialdehyde; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Phytotherapy; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats, Sprague-Dawley; Selenium; Serenoa; Testosterone Propionate | 2018 |
Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Topics: Animals; Antioxidants; Dihydrotestosterone; Fenofibrate; Glutathione Peroxidase; Male; Malondialdehyde; PPAR alpha; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats; Rats, Wistar; Superoxide Dismutase; Testosterone | 2018 |
The effect of dutasteride on microscopic and macroscopic changes of testosterone replacement treatment on prostate tissue.
Topics: 5-alpha Reductase Inhibitors; Animals; Dihydrotestosterone; Disease Models, Animal; Dutasteride; Hormone Replacement Therapy; Humans; Male; Orchiectomy; Precancerous Conditions; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Testosterone; Treatment Outcome | 2018 |
[Efficacy of Kangshuailing Gao on benign prostatic hyperplasia in rats].
Topics: Androgens; Animals; Dihydrotestosterone; Drugs, Chinese Herbal; Estradiol; Finasteride; Male; Organ Size; Prostate; Prostatic Hyperplasia; Random Allocation; Rats; Testosterone; Urological Agents | 2018 |
Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Cell Line; Dihydrotestosterone; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Humans; Injections, Intramuscular; Male; Plant Extracts; Plants, Medicinal; Proliferating Cell Nuclear Antigen; Prostatic Hyperplasia; Rats; Receptors, Androgen; Testosterone Propionate | 2018 |
Serenoa repens extracts: In vitro study of the 5α-reductase activity in a co-culture model for Benign Prostatic Hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Cells, Cultured; Cholestenone 5 alpha-Reductase; Coculture Techniques; Dihydrotestosterone; Dose-Response Relationship, Drug; Epithelial Cells; Ethanol; Fibroblasts; Hexanes; Humans; In Vitro Techniques; Inhibitory Concentration 50; Male; Plant Extracts; Prostatic Hyperplasia; Serenoa; Solvents | 2018 |
Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).
Topics: Aged; Cystectomy; Dihydrotestosterone; Estradiol; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Urinary Bladder Neoplasms | 2019 |
Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis.
Topics: Animals; Apoptosis; Dihydrotestosterone; Male; Phytotherapy; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats, Sprague-Dawley; Testosterone; Testosterone Propionate; Ulmus | 2019 |
Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Cytokines; Dihydrotestosterone; Finasteride; Lespedeza; Male; Organ Size; Plant Extracts; Proliferating Cell Nuclear Antigen; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats; Rats, Wistar; Receptors, Androgen; Testosterone | 2019 |
[Study on effect of extract from Tibetan medicine Urtica hyperborean on anti-prostatic hyperplasia].
Topics: Animals; Dihydrotestosterone; Epidermal Growth Factor; Male; Medicine, Tibetan Traditional; Mice; Plant Extracts; Prostatic Hyperplasia; Proto-Oncogene Proteins c-bcl-2; Testosterone Propionate; Urticaceae | 2019 |
6-sialyllactose ameliorates dihydrotestosterone-induced benign prostatic hyperplasia through suppressing VEGF-mediated angiogenesis.
Topics: Animals; Computational Biology; Culture Media, Conditioned; Dihydrotestosterone; Human Umbilical Vein Endothelial Cells; Humans; Lactose; Male; Neovascularization, Pathologic; Prostatic Hyperplasia; Rats; Sialic Acids; Vascular Endothelial Growth Factor A | 2019 |
Preventive effects of Monascus on androgen-related diseases: androgenetic alopecia, benign prostatic hyperplasia, and prostate cancer.
Topics: Administration, Oral; Aging; Alopecia; Animals; Dihydrotestosterone; Male; Methylnitrosourea; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Monascus; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Testosterone | 2013 |
Inhibition of androgen induces autophagy in benign prostate epithelial cells.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Androgens; Apoptosis; Autophagy; Cell Line; Cell Survival; Dihydrotestosterone; Epithelial Cells; Finasteride; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia | 2014 |
Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH.
Topics: Actins; Animals; Biomarkers; Blood Pressure; Dihydrotestosterone; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 2; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Male; Malondialdehyde; Oxidative Stress; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow; Transforming Growth Factor beta1 | 2014 |
α-Spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Male; Organ Size; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Stigmasterol; Testosterone | 2014 |
Low intraprostatic DHT promotes the infiltration of CD8+ T cells in BPH tissues via modulation of CCL5 secretion.
Topics: CD8-Positive T-Lymphocytes; Cell Line; Cell Movement; Chemokine CCL5; Dihydrotestosterone; Finasteride; Flow Cytometry; Humans; Immunohistochemistry; In Vitro Techniques; Male; Prostate; Prostatic Hyperplasia | 2014 |
Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Topics: Androgens; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Dihydrotestosterone; Epithelial-Mesenchymal Transition; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Immunoenzyme Techniques; Male; MicroRNAs; Neoplasms, Hormone-Dependent; Prostatic Hyperplasia; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured; Wound Healing; Zinc Finger E-box Binding Homeobox 2 | 2014 |
A population-based nested case-control study: the use of 5-alpha-reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Case-Control Studies; Comorbidity; Databases, Factual; Dihydrotestosterone; Female; Finasteride; Humans; Longitudinal Studies; Male; Odds Ratio; Osteoporosis; Prostate; Prostatic Hyperplasia; Risk Factors; Testosterone | 2015 |
Treatment of benign prostatic hyperplasia with Croton membranaceus in an experimental animal model.
Topics: Animals; Croton; Dihydrotestosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Finasteride; Male; Medicine, Traditional; Plant Extracts; Plant Roots; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley | 2014 |
Significant association of metabolic indices, lipid profile, and androgen levels with prostate cancer.
Topics: Aged; Body Mass Index; Case-Control Studies; Dihydrotestosterone; Follow-Up Studies; Humans; Insulin; Lipids; Male; Neoplasm Grading; Neoplasm Staging; Prognosis; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 2014 |
Antrodan, a β-glucan obtained from Antrodia cinnamomea mycelia, is beneficial to benign prostate hyperplasia.
Topics: Animals; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antrodia; Aromatase; beta-Glucans; Cadherins; Cholesterol, HDL; Cholesterol, LDL; Cyclooxygenase 2; Dihydrotestosterone; Disease Models, Animal; Down-Regulation; Epithelial-Mesenchymal Transition; Estradiol; Humans; Interleukin-1; Male; Middle Aged; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Androgen; Testosterone; Up-Regulation; Vimentin | 2015 |
Is there a relationship between androgenic alopecia and benign prostatic hyperplasia?
Topics: Alopecia; Cross-Sectional Studies; Dihydrotestosterone; Humans; Incidence; Iran; Male; Middle Aged; Organ Size; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Ultrasonography | 2015 |
Ischemia in pelvic organs as an independent pathogenic factor in the development of benign prostatic hyperplasia and urinary bladder dysfunction.
Topics: Animals; Dihydrotestosterone; Estradiol; Ischemia; Male; Prostate; Prostatic Hyperplasia; Rats; Testosterone; Urinary Bladder; Vena Cava, Inferior | 2015 |
Bee venom suppresses testosterone-induced benign prostatic hyperplasia by regulating the inflammatory response and apoptosis.
Topics: Animals; Apoptosis; Bee Venoms; Blotting, Western; Dihydrotestosterone; Inflammation; Male; Organ Size; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Testosterone | 2015 |
Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia.
Topics: Animals; Anoctamin-1; Calcium; Calcium Channels; Cell Proliferation; Chloride Channels; Chromatin Immunoprecipitation; Dihydrotestosterone; Disease Models, Animal; Epithelial Cells; Gene Knockdown Techniques; Genes, Reporter; Humans; Hyperplasia; Injections; Ion Channel Gating; Luciferases; Male; Neoplasm Proteins; Promoter Regions, Genetic; Prostate; Prostatic Hyperplasia; Rats, Wistar; Response Elements; RNA, Small Interfering; Tannins; Testosterone; Up-Regulation | 2015 |
Studies on Chromatographic Fingerprint and Fingerprinting Profile-Efficacy Relationship of Saxifraga stolonifera Meerb.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Acid Phosphatase; Animals; Chromatography, High Pressure Liquid; Dihydrotestosterone; Least-Squares Analysis; Male; Mice; Plant Extracts; Principal Component Analysis; Prostatic Hyperplasia; Saxifragaceae; Testosterone | 2015 |
Anti-proliferation effects of Cistanches salsa on the progression of benign prostatic hyperplasia.
Topics: Animals; Apoptosis; Cell Proliferation; Cistanche; Cyclooxygenase 2; Dihydrotestosterone; Disease Progression; Male; Nitric Oxide Synthase Type II; Organ Size; Phytotherapy; Plant Extracts; Plants, Medicinal; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley | 2016 |
Anti-Proliferation Effects of Garlic (Allium sativum L.) on the Progression of Benign Prostatic Hyperplasia.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Proliferation; Dihydrotestosterone; Garlic; Male; Phytotherapy; Prostate; Prostatic Hyperplasia; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar | 2016 |
Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats.
Topics: 5-alpha Reductase Inhibitors; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Dihydrotestosterone; Hyperplasia; Inflammation; Male; Nitric Oxide Synthase Type II; Oryza; Phytotherapy; Plant Extracts; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Rats, Sprague-Dawley; Seeds | 2016 |
Effect of kolaviron, a biflavanoid complex from Garcinia kola on some biochemical parameters in experimentally induced benign prostatic hyperplasic rats.
Topics: Animals; Dihydrotestosterone; Estradiol; Flavanones; Flavonoids; Garcinia kola; Male; Plant Extracts; Prostatic Hyperplasia; Rats; Rats, Wistar; Seeds | 2016 |
Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
Topics: Animals; Benzylamines; Biomarkers; Dihydrotestosterone; Dose-Response Relationship, Drug; Finasteride; Male; Naphthalenes; Organ Size; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Receptors, Androgen; Testosterone | 2016 |
High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Chromatography, Liquid; Dihydrotestosterone; Humans; Male; Middle Aged; Neoplasm Grading; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Tandem Mass Spectrometry; Testosterone | 2017 |
Bawu decoction () ameliorates benign prostatic hyperplasia in rats.
Topics: Animals; Body Weight; Dihydrotestosterone; Drugs, Chinese Herbal; Epithelium; Male; Organ Size; Prostate; Prostatic Hyperplasia; Rats, Wistar; Testosterone | 2017 |
CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway.
Topics: CD8-Positive T-Lymphocytes; Cell Line; Cell Proliferation; Chemokine CCL5; Coculture Techniques; Cyclin D1; Dihydrotestosterone; Epithelial Cells; Finasteride; Gene Expression Regulation; Humans; Male; Phosphorylation; Pimozide; Prostatic Hyperplasia; Signal Transduction; STAT5 Transcription Factor | 2017 |
Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
Topics: Androgens; Dihydrotestosterone; Finasteride; Humans; Male; Nandrolone; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Testosterone; Testosterone Congeners | 2009 |
Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
Topics: Androgens; Animals; Apoptosis; Body Weight; Cell Differentiation; Cell Proliferation; Dihydrotestosterone; Epithelial Cells; Genotype; Integrases; Male; Mice; Mice, Knockout; Orchiectomy; Organ Size; Precancerous Conditions; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Regeneration; RNA, Messenger; Stromal Cells; Testosterone | 2009 |
Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology.
Topics: Androgens; Animals; Cell Proliferation; Dihydrotestosterone; Doxazosin; Epithelial Cells; Extracellular Matrix; Finasteride; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Rats, Wistar; RNA, Messenger; Testosterone; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta1 | 2010 |
Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men.
Topics: California; Dihydrotestosterone; Epidemiologic Methods; Humans; Hypogonadism; Independent Living; Male; Middle Aged; Prostatic Hyperplasia; Prostatism; Testosterone | 2010 |
Saturable binding of finasteride to steroid 5alpha-reductase as determinant of nonlinear pharmacokinetics.
Topics: 5-alpha Reductase Inhibitors; Animals; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Male; Nonlinear Dynamics; Prostatic Hyperplasia; Prostatic Neoplasms; Rats | 2010 |
Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo Study.
Topics: Dihydrotestosterone; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Risk Factors; Time Factors | 2010 |
The effect of estrogen supplementation on cell proliferation and expression of c-kit positive cells in the rat prostate.
Topics: Androgens; Animals; Body Weight; Cell Division; Dietary Supplements; Dihydrotestosterone; Estradiol; Estrogens; Ki-67 Antigen; Leydig Cells; Male; Organ Size; Prostate; Prostatic Hyperplasia; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Testosterone | 2010 |
Temporary placement of a covered, retrievable, barbed stent for the treatment of hormone-induced benign prostatic hyperplasia: technical feasibility and histologic changes in canine prostates.
Topics: Animals; Atrophy; Coated Materials, Biocompatible; Device Removal; Dihydrotestosterone; Disease Models, Animal; Dogs; Estradiol; Feasibility Studies; Fibrosis; Male; Prostate; Prostatic Hyperplasia; Prosthesis Design; Radiography; Stents; Time Factors; Urethra; Urethral Obstruction | 2010 |
Summaries for Patients: Daily application of dihydrotestosterone gel does not prevent age-related growth of the prostate gland.
Topics: Administration, Cutaneous; Androgens; Body Composition; Bone Density; Dihydrotestosterone; Gels; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Ultrasonography | 2010 |
Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
Topics: 5-alpha Reductase Inhibitors; Animals; Apoptosis; Aromatase; Benzopyrans; Cell Proliferation; Cell Survival; Cells, Cultured; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Finasteride; Gene Expression Regulation; Humans; Male; Piperidines; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Androgen; RNA, Messenger; Selective Estrogen Receptor Modulators; Signal Transduction; Stromal Cells; Tamoxifen; Testosterone; Tissue Culture Techniques | 2012 |
Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40-79 years.
Topics: Adult; Aged; Body Mass Index; Dihydrotestosterone; Estradiol; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Organ Size; Prostate; Prostatic Hyperplasia | 2012 |
Oral exposure to low-dose bisphenol A aggravates testosterone-induced benign hyperplasia prostate in rats.
Topics: Administration, Oral; Animals; Benzhydryl Compounds; Dihydrotestosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Endocrine Disruptors; Epithelial Cells; Estradiol; Estrogens, Non-Steroidal; Male; Organ Size; Phenols; Prolactin; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Testosterone | 2011 |
Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Aged; Androgens; Cells, Cultured; Dihydrotestosterone; Finasteride; Humans; Immunohistochemistry; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Testosterone; Up-Regulation | 2011 |
Serum testosterone levels significantly correlate with nocturia in men aged 40-79 years.
Topics: Adult; Aged; Dihydrotestosterone; Estradiol; Humans; Male; Middle Aged; Nocturia; Prostate; Prostatic Hyperplasia; Testosterone; Ultrasonography; Urination Disorders | 2011 |
Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats.
Topics: Administration, Oral; Animals; Caryophyllaceae; Dihydrotestosterone; Disease Models, Animal; Male; Methanol; Orchiectomy; Organ Size; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Testosterone | 2012 |
Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Male; Organ Size; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats; Rats, Wistar; Triterpenes; Ursolic Acid | 2012 |
Dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic enlargement.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Dihydrotestosterone; Drug Combinations; Dutasteride; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Testosterone | 2012 |
Fraction of macroporous resin from Smilax china L. inhibits testosterone propionate-induced prostatic hyperplasia in castrated rats.
Topics: Animals; Castration; Dihydrotestosterone; Male; Phytotherapy; Plant Extracts; Prostate; Prostatic Hyperplasia; Random Allocation; Rats; Rats, Sprague-Dawley; Resins, Plant; Rhizome; Smilax; Testosterone Propionate | 2012 |
Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Drugs, Chinese Herbal; Humans; Male; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Testosterone | 2012 |
Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells.
Topics: Aged; Aged, 80 and over; Androgens; CD4-Positive T-Lymphocytes; Cell Proliferation; Cells, Cultured; Coculture Techniques; Cohort Studies; Cyclooxygenase 2; Cytokines; Dihydrotestosterone; Gene Expression; Humans; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Lymphocyte Activation; Male; Microscopy, Fluorescence; Middle Aged; Prostatic Hyperplasia; Receptors, Androgen; Testosterone; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2012 |
Management of experimental benign prostatic hyperplasia in rats using a food-based therapy containing Telfairia occidentalis seeds.
Topics: Acid Phosphatase; Animals; Cucurbita; Dihydrotestosterone; Disease Management; Estradiol; Humans; Immunoenzyme Techniques; Male; Nigeria; Organ Size; Plant Extracts; Prostate; Prostatic Hyperplasia; Protein Tyrosine Phosphatases; Rats; Rats, Wistar; Seeds; Testosterone | 2011 |
Validation of a sequential extraction and liquid chromatography-tandem mass spectrometric method for determination of dihydrotestosterone, androstanediol and androstanediol-glucuronide in prostate tissues.
Topics: Androstane-3,17-diol; Benzenesulfonates; Chromatography, Liquid; Dihydrotestosterone; Drug Stability; Humans; Male; Prostate; Prostatic Hyperplasia; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
Chronic caffeine intake increases androgenic stimuli, epithelial cell proliferation and hyperplasia in rat ventral prostate.
Topics: Administration, Oral; Androgens; Animals; Apoptosis; Caffeine; Cell Proliferation; Central Nervous System Stimulants; Chronic Disease; Dihydrotestosterone; Dose-Response Relationship, Drug; Male; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Receptors, Androgen; Signal Transduction; Testosterone; Water Supply | 2012 |
Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.
Topics: Aged; Androgens; Biomarkers; Case-Control Studies; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Male; Middle Aged; Oxidoreductases; Polymorphism, Genetic; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Receptors, Androgen; Testosterone; Trinucleotide Repeats | 2002 |
Comparative analysis of prostatic acid phosphatase and prostate-specific antigen mRNA levels in hyperplastic prostate stimulated with steroid hormones and growth factors.
Topics: Acid Phosphatase; Base Sequence; Blotting, Northern; Dihydrotestosterone; Epidermal Growth Factor; Estradiol; Fibroblast Growth Factor 2; Growth Substances; Humans; Male; Molecular Sequence Data; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Protein Tyrosine Phosphatases; RNA, Messenger; Steroids; Tumor Cells, Cultured | 2002 |
Rapid HPLC-electrospray tandem mass spectrometric assay for urinary testosterone and dihydrotestosterone glucuronides from patients with benign prostate hyperplasia.
Topics: Adult; Biomarkers; Chromatography, High Pressure Liquid; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Spectrometry, Mass, Electrospray Ionization; Testosterone | 2003 |
5 alpha-reductase-catalyzed conversion of testosterone to dihydrotestosterone is increased in prostatic adenocarcinoma cells: suppression by 15-lipoxygenase metabolites of gamma-linolenic and eicosapentaenoic acids.
Topics: Adenocarcinoma; Animals; Arachidonate 15-Lipoxygenase; Cells, Cultured; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Eicosapentaenoic Acid; gamma-Linolenic Acid; Male; Oxidoreductases; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone; Tumor Cells, Cultured | 2002 |
Androgen and prostatic stroma.
Topics: Animals; Biomarkers; Cell Differentiation; Cell Division; Cells, Cultured; Dihydrotestosterone; Dogs; Estradiol; Fibroblast Growth Factor 2; Gene Expression; Humans; Male; Muscle, Smooth; Orchiectomy; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Estrogen; RNA, Messenger; Stromal Cells; Testosterone; Transforming Growth Factor beta | 2003 |
The role of dihydrotestosterone in benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Androgens; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Testosterone | 2003 |
Growth factor expression in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens.
Topics: Androgens; Androstenedione; Animals; Calcium Phosphates; Dihydrotestosterone; Drug Implants; Endothelium, Vascular; Epidermal Growth Factor; Fibroblast Growth Factors; Male; Prostate; Prostatic Hyperplasia; Rats; Reference Values; Testosterone | 2003 |
Anti-androgenic action by red clover-derived dietary isoflavones reduces non-malignant prostate enlargement in aromatase knockout (ArKo) mice.
Topics: Animal Feed; Animals; Aromatase; Body Weight; Dihydrotestosterone; Estrogens; Gene Expression; Isoflavones; Male; Mice; Mice, Knockout; Orchiectomy; Organ Size; Phytotherapy; Plant Preparations; Prostate; Prostatic Hyperplasia; Testis; Testosterone; Trifolium | 2003 |
Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aging; Androgen Antagonists; Animals; Apoptosis; Atrophy; Calcitriol; CHO Cells; Clusterin; Cricetinae; Dihydrotestosterone; Gene Expression; Glycoproteins; Gonadal Steroid Hormones; Humans; Luteinizing Hormone; Male; Molecular Chaperones; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Androgen; Receptors, Fibroblast Growth Factor; Signal Transduction; Stromal Cells; Testosterone; Up-Regulation | 2003 |
Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas.
Topics: ADAM Proteins; ADAM10 Protein; ADAM17 Protein; Adenocarcinoma; Amyloid Precursor Protein Secretases; Animals; Blotting, Northern; Blotting, Western; Cell Division; Cell Line, Tumor; Dihydrotestosterone; Disintegrins; Humans; Male; Membrane Proteins; Metalloendopeptidases; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Structure, Tertiary; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-3; Tissue Inhibitor of Metalloproteinases; Up-Regulation | 2003 |
[Establishment of prostatic hyperplasia model with castration beagle canines].
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Dogs; Male; Orchiectomy; Prostatic Hyperplasia; Testosterone Propionate | 2003 |
Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
Topics: Age Factors; Androgens; Animals; Dihydrotestosterone; Disease Models, Animal; Estradiol; Humans; Male; Pressure; Prostatic Hyperplasia; Urethral Obstruction; Urination Disorders; Urodynamics | 2004 |
Effects of steroids on oxytocin secretion by the human prostate in vitro.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androgens; Animals; Cyproterone Acetate; Diethylstilbestrol; Dihydrotestosterone; Humans; In Vitro Techniques; Male; Middle Aged; Oxytocin; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Rats; Testosterone; Time Factors | 2004 |
Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP.
Topics: ADAM Proteins; ADAM10 Protein; Amyloid Precursor Protein Secretases; Androgens; Blotting, Western; Cell Membrane; Cell Nucleus; Dihydrotestosterone; Epidermal Growth Factor; Gene Expression Regulation; Humans; Immunoenzyme Techniques; In Situ Hybridization; Insulin-Like Growth Factor I; Male; Membrane Proteins; Metalloendopeptidases; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2004 |
The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor.
Topics: Androgen Antagonists; Androgens; Androstenediol; Cell Division; Cell Line, Tumor; Dihydrotestosterone; DNA Primers; Genes, Reporter; Humans; Male; Mutation; Polymerase Chain Reaction; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Transfection | 2004 |
Relationship between upregulated oestrogen receptors and expression of growth factors in cultured, human, prostatic stromal cells exposed to estradiol or dihydrotestosterone.
Topics: Dihydrotestosterone; Estradiol; Flow Cytometry; Growth Substances; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Estrogen; Stromal Cells; Tumor Cells, Cultured; Up-Regulation | 2004 |
Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation.
Topics: Animals; Cell Cycle; Cell Cycle Proteins; Dihydrotestosterone; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Finasteride; Male; Organ Size; Prostate; Prostatic Hyperplasia; Quercetin; Rats; Rats, Sprague-Dawley; Testosterone | 2004 |
Suppression of cyclooxygenase-2 overexpression by 15S-hydroxyeicosatrienoic acid in androgen-dependent prostatic adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Arachidonic Acid; Cyclooxygenase 2; Dihydrotestosterone; Dinoprostone; Disease Models, Animal; Disease Progression; Eicosanoic Acids; gamma-Linolenic Acid; Humans; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Tumor Cells, Cultured | 2004 |
Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
Topics: Androgens; Animals; Cell Line; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Dihydrotestosterone; DNA-Binding Proteins; Enzyme Inhibitors; Epithelial Cells; Gene Expression; Growth Substances; Humans; Janus Kinase 2; Male; Mutation; Phenotype; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Receptors, Retinoic Acid; RNA, Messenger; STAT3 Transcription Factor; Trans-Activators; Transfection; Tyrphostins | 2005 |
Determination of prostatic androgens in 10 mg of tissue using liquid chromatography-tandem mass spectrometry with charged derivatization.
Topics: Chromatography, Liquid; Dihydrotestosterone; Humans; Hydrazines; Male; Molecular Structure; Prostatic Hyperplasia; Pyridines; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Testosterone; Time Factors | 2005 |
The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Alanine; Alleles; Arginine; Biomarkers, Tumor; Case-Control Studies; Dihydrotestosterone; Disease Progression; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Leucine; Luteinizing Hormone; Male; Middle Aged; Point Mutation; Polymorphism, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Risk Factors; Sex Hormone-Binding Globulin; Sweden; Terminal Repeat Sequences; Testosterone; Threonine; Valine | 2005 |
2-hydrazino-1-methylpyridine: a highly sensitive derivatization reagent for oxosteroids in liquid chromatography-electrospray ionization-mass spectrometry.
Topics: Androgens; Chromatography, Liquid; Dihydrotestosterone; Humans; Hydrazines; Ketosteroids; Male; Prostate; Prostatic Hyperplasia; Pyridines; Pyridinium Compounds; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Testosterone | 2005 |
Reductase activity of 17beta-hydroxysteroid oxidoreductase in prostatic tumors of different histological structure.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Biopsy; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Testosterone | 2005 |
Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase.
Topics: Cell Line, Transformed; Cluster Analysis; Dihydrotestosterone; Epithelial Cells; Gene Expression Regulation; Humans; Male; Oligonucleotide Array Sequence Analysis; Prostate-Specific Antigen; Prostatic Hyperplasia; Receptors, Androgen; Response Elements; Telomerase | 2007 |
Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Androgen-Binding Protein; Animals; Antigens, Viral, Tumor; Apoptosis; Azasteroids; Cell Division; Cell Transformation, Neoplastic; Dihydrotestosterone; Disease Models, Animal; Dutasteride; Enzyme Inhibitors; Female; Male; Membrane Proteins; Mice; Mice, Transgenic; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Seminal Vesicles; Transgenes | 2007 |
Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer.
Topics: ADAM Proteins; ADAM10 Protein; Aged; Aged, 80 and over; Amyloid Precursor Protein Secretases; Biopsy; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Dihydrotestosterone; Disease Progression; DNA Primers; Humans; Immunohistochemistry; Male; Membrane Proteins; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Transport; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering | 2007 |
Therapeutic effect of ACTICOA powder, a cocoa polyphenolic extract, on experimentally induced prostate hyperplasia in Wistar-Unilever rats.
Topics: Animals; Cacao; Dihydrotestosterone; Drinking; Eating; Flavonoids; Male; Organ Size; Phenols; Plant Extracts; Polyphenols; Powders; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Seeds; Testosterone Propionate; Weight Gain | 2007 |
Steroid 5-alpha reductase type 2 activity in biopsies from malignant and normal prostatic tissues.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Aged, 80 and over; Biopsy; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 2008 |
Do's and don'ts in stereological pathology or possibilities of stereological-biochemical correlation in uropathology.
Topics: Adult; Age Factors; Aged; Cell Count; Dihydrotestosterone; Humans; Male; Middle Aged; Muscle, Smooth; Prostatic Hyperplasia | 1984 |
Measurements of prolactin and androgens in patients with prostatic diseases.
Topics: Adult; Aged; Antineoplastic Agents; Castration; Dihydrotestosterone; Estradiol Congeners; Female; Humans; Male; Middle Aged; Prolactin; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1980 |
Methodologic basis for the radioimmunoassay of endogenous steroids in human prostatic tissue.
Topics: Adenocarcinoma; Adult; Aged; Dihydrotestosterone; Estradiol; Estrone; Humans; Male; Middle Aged; Progesterone; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Radioimmunoassay; Steroids; Testosterone | 1980 |
Subcellular distribution of androgens in hyperplastic human prostate.
Topics: Androgens; Androstenediols; Cell Nucleus; Cross Reactions; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Radioimmunoassay; Subcellular Fractions; Testosterone | 1980 |
Binding of chlormadinone acetate to cytosol from human benign prostatic hypertrophy.
Topics: Androgen Antagonists; Chlormadinone Acetate; Cytosol; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia | 1980 |
Tissue androgen concentrations in golden hamsters with benign prostatic tumours.
Topics: Androgens; Androstane-3,17-diol; Androstanes; Androsterone; Animals; Castration; Cricetinae; Dihydrotestosterone; Male; Mesocricetus; Prostate; Prostatic Hyperplasia; Testosterone | 1980 |
Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia.
Topics: Adult; Aged; Aging; Androstane-3,17-diol; Biotransformation; Dihydrotestosterone; Humans; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Prostatic Hyperplasia; Testosterone | 1980 |
Binding to R 1881 (methyltrienolone) of proteins from human benign prostatic hypertrophy.
Topics: Cell Extracts; Chromatography, Gel; Cyproterone; Cytosol; Dihydrotestosterone; Estrenes; Humans; Male; Metribolone; Prostatic Hyperplasia; Protein Binding; Tritium | 1980 |
Prostatic tissue distribution of 17 beta-hydroxy-5 alpha-androstan-3-one and of androgen receptors in benign hyperplasia.
Topics: Cell Nucleus; Cytosol; Dihydrotestosterone; Epithelium; Humans; Male; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid | 1980 |
Supranormal nuclear content of 5 alpha-dihydrotestosterone in benign hyperplastic prostate of humans.
Topics: Aged; Androstenediols; Cell Nucleus; Cytosol; Dihydrotestosterone; Humans; Isomerism; Male; Middle Aged; Prostate; Prostatic Hyperplasia | 1980 |
Correlation between clinical response to antiandrogenic therapy and occurrence of receptors in human prostatic cancer.
Topics: Aged; Androgen Antagonists; Cyproterone; Dihydrotestosterone; Estradiol; Humans; Hydrocortisone; Male; Middle Aged; Progesterone; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Steroid | 1980 |
Total and SHBG-bound testosterone and 5 alpha-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma.
Topics: Aged; Dihydrotestosterone; Humans; Male; Prostatectomy; Prostatic Hyperplasia; Sex Hormone-Binding Globulin; Testosterone | 1980 |
Evaluation of androgen metabolism studies in human prostate cancer--correlation with zinc levels.
Topics: Aged; Androgens; Androstenedione; Carcinoma; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Zinc | 1980 |
Dihydrotestosterone receptors in the human prostate. I. Nuclear concentration in normal, benign, and malignant tissues.
Topics: Binding, Competitive; Cell Nucleus; Chromatography; Dihydrotestosterone; Histological Techniques; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Temperature; Time Factors | 1980 |
Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
Topics: Aging; Androstanols; Animals; Dihydrotestosterone; Dogs; Estradiol; In Vitro Techniques; Male; Prostate; Prostatic Hyperplasia; Testosterone | 1981 |
[Hormonal disturbances in men with a prostatic adenoma (author's transl)].
Topics: Adult; Aged; Dihydrotestosterone; Estrogens; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Hyperplasia; Testosterone | 1980 |
Interferences of zearalenone, zearalanol or estradiol-17 beta with the steroid-metabolizing enzymes of the human prostate gland.
Topics: 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Dihydrotestosterone; Estradiol; Humans; Kinetics; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Resorcinols; Testosterone; Zearalenone; Zeranol | 1980 |
Altered androgen metabolism in carcinoma of the prostate.
Topics: Androstenediols; Androstenedione; Culture Techniques; Dihydrotestosterone; Male; Oxidation-Reduction; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1981 |
Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
Topics: Adult; Aged; Androgens; Androstane-3,17-diol; Dihydrotestosterone; Estradiol; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1981 |
Peripheral and prostatic vein steroid concentrations in benign prostatic hypertrophy patients before and after removal of the adenoma.
Topics: Aged; Dihydrotestosterone; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Prostate; Prostatectomy; Prostatic Hyperplasia; Veins | 1980 |
Elevated intranuclear dihydrotestosterone in prostatic hyperplasia of aging dogs.
Topics: Aging; Androstane-3,17-diol; Animals; Cell Nucleus; Cytosol; Dihydrotestosterone; Dogs; Male; Microsomes; Mitochondria; Prostate; Prostatic Hyperplasia | 1981 |
Interaction of prolactin and testosterone in the human prostate.
Topics: Dihydrotestosterone; Humans; Male; Prolactin; Prostatic Hyperplasia; Prostatic Neoplasms; Stimulation, Chemical; Testosterone; Thyrotropin-Releasing Hormone | 1981 |
Suppressive effects of surgical stress on circulating androgens during and after prostatectomy.
Topics: Aged; Dihydrotestosterone; Humans; Male; Prostatectomy; Prostatic Hyperplasia; Stress, Physiological; Testosterone | 1981 |
Studies of the nuclear 5 alpha-reductase of human hyperplastic prostatic tissue.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Biotransformation; Cell Nucleus; Cyproterone; Dihydrotestosterone; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Oxidoreductases; Prostatic Hyperplasia; Proteins | 1981 |
The effect of therapy on the concentration and occupancy of androgen receptors in human prostatic cytosol.
Topics: Castration; Cytosol; Dihydrotestosterone; DNA; Estrogens; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Testosterone | 1980 |
Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates.
Topics: Cytosol; Dihydrotestosterone; Estrenes; Humans; In Vitro Techniques; Male; Metribolone; Norpregnadienes; Promegestone; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone Congeners | 1981 |
Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with sponta
Topics: Androgens; Androstane-3,17-diol; Animals; Castration; Dihydrotestosterone; Dogs; Follicle Stimulating Hormone; Luteinizing Hormone; Male; Pituitary Hormones; Prolactin; Prostatic Hyperplasia; Testosterone | 1981 |
Androgen metabolism in the epithelial and stromal components of the human hyperplastic prostate.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Dihydrotestosterone; Epithelial Cells; Epithelium; Humans; Male; Prostate; Prostatic Hyperplasia; Testosterone | 1981 |
The effects of flutamide on total DHT and nuclear DHT levels in the human prostate.
Topics: Acid Phosphatase; Administration, Oral; Anilides; Cell Nucleus; Dihydrotestosterone; Flutamide; Humans; Male; Prostate; Prostatic Hyperplasia; Testosterone | 1981 |
Androgen receptor content of normal and hyperplastic human prostate.
Topics: Adult; Aged; Cell Nucleus; Cytosol; Dihydrotestosterone; Estrenes; Humans; Kinetics; Male; Metribolone; Middle Aged; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid; Testosterone Congeners | 1982 |
[Identification and characteristics of steroid hormone receptor binding properties in the nuclear fraction of human prostatic adenoma].
Topics: Cell Nucleus; Dexamethasone; Dihydrotestosterone; Estradiol; Humans; Hydrocortisone; Male; Progesterone; Promegestone; Prostatic Hyperplasia; Receptors, Steroid | 1981 |
Analysis of androgen receptors in the human prostate by isoelectric focussing in polyacrylamide gel.
Topics: Cell Nucleus; Cytoplasm; Dihydrotestosterone; Estrenes; Glycine; Heparin; Humans; Isoelectric Focusing; Male; Metribolone; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid; Trypsin | 1981 |
Androgens and prostate-specific acid phosphatase in whole tissue and in separated epithelium from human benign prostatic hypertrophic glands.
Topics: Acid Phosphatase; Androgens; Androstane-3,17-diol; Androstenedione; Androsterone; Dihydrotestosterone; Epithelium; Humans; Male; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Testosterone | 1981 |
[The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)].
Topics: Aged; Dihydrotestosterone; Estradiol; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Male; Middle Aged; Progesterone; Prostatic Hyperplasia; Spironolactone; Testosterone | 1981 |
Testosterone metabolism of fibroblasts grown from prostatic carcinoma, benign prostatic hyperplasia and skin fibroblasts.
Topics: Androstanes; Androsterone; Carcinoma; Cells, Cultured; Chromatography, Thin Layer; Dihydrotestosterone; Fibroblasts; Humans; In Vitro Techniques; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Skin; Stereoisomerism; Testosterone; Tritium | 1982 |
Proliferation of human prostatic epithelial cells in culture: aspects of identification.
Topics: Cell Count; Cell Division; Cells, Cultured; Culture Media; Dihydrotestosterone; Epithelium; Humans; In Vitro Techniques; Male; Microscopy, Electron; Prostatic Hyperplasia; Testosterone | 1982 |
Partial characterization of stromal and epithelial forms of 5 alpha-reductase in human prostate.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adolescent; Adult; Aged; Dihydrotestosterone; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; NADP; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1981 |
Polyamines and prostatic function.
Topics: Adult; Aged; Castration; Cyclic AMP; Dihydrotestosterone; Humans; Male; Middle Aged; Ornithine Decarboxylase; Polyamines; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Kinases; Seminal Vesicles | 1981 |
Responses of serum levels of testicular steroid hormones to hCG stimulation in patients with prostatic cancer and benign prostatic hypertrophy.
Topics: Aged; Androsterone; Chorionic Gonadotropin; Dihydrotestosterone; Estradiol; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Testicular Hormones; Testosterone | 1981 |
Androphilic proteins in the human prostate.
Topics: Androgen-Binding Protein; Carrier Proteins; Cell Nucleus; Cytosol; Dihydrotestosterone; Estrenes; Humans; Male; Metribolone; Promegestone; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms | 1981 |
Studies of the cytosol 3 alpha-hydroxysteroid dehydrogenase of human prostatic tissue: comparison of enzyme activities in hyperplastic, malignant and normal tissues.
Topics: 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); 3-Hydroxysteroid Dehydrogenases; Adult; Androstanols; Cytosol; Dihydrotestosterone; Humans; Hydrogen-Ion Concentration; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Subcellular Fractions | 1982 |
Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
Topics: Cytosol; Dihydrotestosterone; Estrenes; Humans; Kinetics; Male; Metribolone; Molybdenum; Progesterone Congeners; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Triamcinolone Acetonide | 1981 |
Endogenous androgen levels in epithelium and stroma of human benign prostatic hyperplasia and normal prostate.
Topics: Adult; Aged; Androgens; Androstane-3,17-diol; Cell Nucleus; Dihydrotestosterone; DNA; Epithelium; Humans; Male; Prostate; Prostatic Hyperplasia | 1982 |
Microautoradiographic studies on distribution of 5 alpha-dihydrotestosterone, cyproterone acetate and oestradiol-17 beta in human prostatic hyperplasia tissue transplanted to juvenile rats.
Topics: Aged; Animals; Autoradiography; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Estradiol; Humans; Male; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred Strains; Silver; Staining and Labeling; Transplantation, Heterologous | 1982 |
[Endogenous androgen levels of human prostatic tissues].
Topics: Aged; Androgens; Androsterone; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Radioimmunoassay; Testosterone | 1982 |
Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Aged; Androstane-3,17-diol; Dihydrotestosterone; Etiocholanolone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Testosterone | 1983 |
Characterization of the cytosol androgen receptor of the human prostate.
Topics: Centrifugation, Density Gradient; Cytosol; Dihydrotestosterone; Estrenes; Humans; Kinetics; Male; Metribolone; Molybdenum; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid; Testosterone; Triamcinolone Acetonide | 1983 |
Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.
Topics: 17-alpha-Hydroxyprogesterone; Age Factors; Aged; Dihydrotestosterone; Estradiol; Estrone; Humans; Hydrocortisone; Hydroxyprogesterones; Male; Middle Aged; Progesterone; Prostatic Hyperplasia; Prostatic Neoplasms; Reference Values; Testosterone | 1982 |
[Endocrine factors implicated in the pathogenesis of prostatic adenoma].
Topics: Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen | 1982 |
Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.
Topics: Aged; Aging; Androgens; Dihydrotestosterone; Estrogens; Humans; Kinetics; Leydig Cells; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Testosterone | 1982 |
Androgen receptor in electroresected and cold punch-resected specimens. Usefulness of Kaplan cold punch resectoscope.
Topics: Chromatography, Thin Layer; Cold Temperature; Cytological Techniques; Dihydrotestosterone; Electrosurgery; Histological Techniques; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid | 1983 |
Nuclear androgen receptors in the epithelium and stroma of human benign prostatic hypertrophic glands.
Topics: Cell Nucleus; Centrifugation, Density Gradient; Dihydrotestosterone; Electrophoresis, Agar Gel; Epithelium; Humans; Male; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid | 1983 |
Nuclear androgen receptors of human prostatic tissue--a quantitative histological study.
Topics: Adenocarcinoma; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid | 1983 |
5 alpha-reductase activity in stroma and epithelium of rat prostate and epididymis. A contribution to elucidation of the mechanism for development of hyperplastic growth of prostatic tissue.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Chromatography, Thin Layer; Dihydrotestosterone; Epididymis; Hydrogen-Ion Concentration; Male; NADP; Oxidoreductases; Prostate; Prostatic Hyperplasia; Proteins; Rats; Rats, Inbred Strains; Testosterone | 1983 |
Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aging; Animals; Dihydrotestosterone; Dogs; Male; Prostate; Prostatic Hyperplasia | 1983 |
Androgen receptors in rat and human prostate.
Topics: Animals; Cell Nucleus; Cytoplasm; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Rats; Receptors, Androgen; Receptors, Estrogen; Receptors, Steroid; Sex Hormone-Binding Globulin | 1983 |
Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
Topics: 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Aged; Androgens; Dihydrotestosterone; Epithelium; Estrogens; Humans; Kinetics; Male; Middle Aged; Oxidoreductases; Prostate; Prostatic Hyperplasia | 1983 |
The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue.
Topics: Androstenedione; Androsterone; Breast; Breast Neoplasms; Dihydrotestosterone; Etiocholanolone; Female; Humans; Male; Prostatic Hyperplasia; Testosterone | 1983 |
[Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
Topics: Dihydrotestosterone; Estrenes; Humans; Male; Metribolone; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Testosterone Congeners | 1983 |
Effects of tamoxifen on the levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), 17 beta-oestradiol (E2), total and free testosterone (T) and total and free dihydrotestosterone (DHT) in blood of patients with benign pro
Topics: Dihydrotestosterone; Estradiol; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Male; Prolactin; Prostatic Hyperplasia; Tamoxifen; Testosterone; Time Factors | 1983 |
Circulating unconjugated 5 alpha-androstane-3 alpha, 17 beta-diol in elderly men and patients with prostatic tumours.
Topics: Aged; Androstane-3,17-diol; Androstanols; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms | 1983 |
Studies of the nuclear 5 alpha-reductase of human prostatic tissue: comparison of enzyme activities in hyperplastic, malignant, and normal tissues.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Acid Phosphatase; Dihydrotestosterone; Humans; Male; NADP; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Tissue Distribution | 1983 |
Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal.
Topics: Adult; Aged; Dihydrotestosterone; False Negative Reactions; Humans; Male; Middle Aged; Postmortem Changes; Prostate; Prostatic Hyperplasia; Temperature; Testosterone | 1983 |
Dihydrotestosterone concentration of beagle prostatic tissue: effect of age and hyperplasia.
Topics: Aging; Androstane-3,17-diol; Animals; Castration; Dihydrotestosterone; Dogs; Male; Organ Size; Prostate; Prostatic Hyperplasia | 1983 |
Androgen concentrations in epithelial and stromal cell nuclei of human benign prostatic hypertrophic tissues.
Topics: Androgens; Cell Nucleus; Dihydrotestosterone; Epithelium; Humans; Male; Prostate; Prostatic Hyperplasia; Testosterone | 1983 |
Smooth muscle cell of the canine prostate in spontaneous benign hyperplasia, steroid induced hyperplasia and estrogen or tamoxifen treated dogs.
Topics: Animals; Castration; Dihydrotestosterone; Dogs; Estradiol; Estrogens; Male; Microscopy, Electron; Muscle, Smooth; Prostate; Prostatic Hyperplasia; Tamoxifen | 1983 |
Subcellular distribution of zinc in the benign and malignant human prostate: evidence for a direct zinc androgen interaction.
Topics: Cell Nucleus; Cytosol; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Subcellular Fractions; Testosterone; Zinc | 1984 |
Correlation of estrogen and androgen receptor status in prostatic disease measured by high pressure liquid chromatography.
Topics: Adenocarcinoma; Chromatography, High Pressure Liquid; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Receptors, Steroid | 1984 |
Testosterone metabolism by homogenates of human prostates with benign hyperplasia: effects of zinc, cadmium and other bivalent cations.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Cadmium; Carbon Radioisotopes; Cations, Divalent; Dihydrotestosterone; Edetic Acid; Humans; Kinetics; Male; Prostate; Prostatic Hyperplasia; Testosterone; Zinc | 1984 |
[Studies on the androgen-binding proteins in human benign prostatic hypertrophy].
Topics: Androgen-Binding Protein; Calcium; Carrier Proteins; Cytosol; Dihydrotestosterone; Estrenes; Humans; Ions; Magnesium; Male; Metribolone; Prostate; Prostatic Hyperplasia | 1983 |
[Fundamental and clinical study of the anti-prostatic effect of allylestrenol].
Topics: 5-alpha Reductase Inhibitors; Aged; Allylestrenol; Androgen Antagonists; Animals; Cytosol; Dihydrotestosterone; Drug Evaluation; Estrenes; Follicle Stimulating Hormone; Genitalia, Male; Humans; Luteinizing Hormone; Male; Middle Aged; Organ Size; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred Strains; Testosterone | 1983 |
[Correlations between DHT levels and NBS of R1881 receptor in total tissue, cytosol and nuclear extract of human prostate].
Topics: Adult; Aged; Cell Nucleus; Cytosol; Dihydrotestosterone; Estrenes; Humans; Male; Metribolone; Middle Aged; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid; Subcellular Fractions | 1984 |
[Androgen, progestin and estrogen receptors in the normal human prostate and in pathology].
Topics: Adult; Aged; Cell Nucleus; Cytosol; Dihydrotestosterone; Estradiol; Humans; Ligands; Male; Middle Aged; Progesterone; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Reference Values | 1984 |
Studies on the role of the sex-hormone-binding globulin (SHBG) in prostatic gland hypertrophy in men. II. In vitro research.
Topics: Adult; Cell Nucleus; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Dihydrotestosterone; Female; Humans; Male; Pregnancy; Prostate; Prostatic Hyperplasia; Sex Hormone-Binding Globulin; Testosterone | 1984 |
[Endocrinologic aspects of benign prostatic hyperplasia (prostatic adenoma). (Can hormone therapy of the disease be justified in 1984?)].
Topics: Androgens; Dihydrotestosterone; Estrogens; Humans; Male; Prostate; Prostatic Hyperplasia; Tissue Distribution | 1984 |
Physicochemical characterization of the androgen receptor from hyperplastic human prostate.
Topics: Binding, Competitive; Centrifugation, Density Gradient; Chemical Phenomena; Chemistry, Physical; Dihydrotestosterone; Estrenes; Humans; Male; Metribolone; Molecular Weight; Prostatic Hyperplasia; Protease Inhibitors; Receptors, Androgen; Receptors, Steroid; Testosterone; Triamcinolone Acetonide | 1984 |
Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Animals; Buserelin; Castration; Dihydrotestosterone; Dogs; Estrogens; Hydroxyprogesterones; Male; Progesterone; Prostatic Hyperplasia; Testis; Testosterone | 1984 |
Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgen Antagonists; Animals; Chlormadinone Acetate; Contraceptives, Oral; Dihydrotestosterone; Disease Models, Animal; Dogs; Male; Organ Size; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testosterone; Ultrasonography | 1995 |
Etiology of benign prostatic hyperplasia.
Topics: Aging; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia | 1994 |
Expression of the prostate-specific membrane antigen.
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; Blotting, Western; Cell Line; Cell Membrane; Dihydrotestosterone; Gene Expression; Glutamate Carboxypeptidase II; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Molecular Weight; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Biosynthesis; RNA, Messenger; Testosterone; Transcription, Genetic; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
Natural course of human benign prostatic hyperplasia with relation to urinary disturbance.
Topics: Adult; Biomarkers; Cholesterol; Cholesterol, HDL; Dihydrotestosterone; Estradiol; Humans; Lipids; Male; Middle Aged; Organ Size; Prostate-Specific Antigen; Prostatic Hyperplasia; Reference Values; Regression Analysis; Testosterone; Urine | 1994 |
Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Cell Division; Dihydrotestosterone; Humans; In Vitro Techniques; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Tumor Cells, Cultured | 1994 |
The requirement of the testis in establishing the sensitivity of the canine prostate to develop benign prostatic hyperplasia.
Topics: Aging; Animals; Atrophy; Dihydrotestosterone; Disease Models, Animal; Dogs; Estradiol; Male; Prostate; Prostatic Hyperplasia; Testis; Testosterone | 1994 |
In vivo and in vitro effects of androgen on fibroblast growth factor-2 concentrations in the human prostate.
Topics: Androgen Antagonists; Cell Division; Culture Techniques; Dihydrotestosterone; Fibroblast Growth Factor 2; Flutamide; Humans; Male; Megestrol; Megestrol Acetate; Orchiectomy; Prostate; Prostatic Hyperplasia; Radioimmunoassay | 1994 |
Effect of 5-alpha-reductase inhibition on sex-hormone-binding globulin in elderly men.
Topics: Aged; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Finasteride; Humans; Male; Middle Aged; Oxidoreductases; Prostatic Hyperplasia; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone | 1994 |
Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression.
Topics: 5-alpha Reductase Inhibitors; Animals; Dihydrotestosterone; DNA; Dogs; Finasteride; Magnetic Resonance Imaging; Male; Molecular Structure; Organ Size; Prostate; Prostatic Hyperplasia; Proteins; Structure-Activity Relationship; Time Factors | 1995 |
[Organ culture of human tissue as study model of hormonal and pharmacological regulation of benign prostatic hyperplasia and of prostatic cancer].
Topics: Aged; Aged, 80 and over; Autoradiography; Cell Division; Dihydrotestosterone; Epidermal Growth Factor; Humans; Male; Middle Aged; Models, Biological; Organ Culture Techniques; Prolactin; Prostatic Hyperplasia; Prostatic Neoplasms | 1995 |
Case report: finasteride-induced gynecomastia in a 62-year-old man.
Topics: Dihydrotestosterone; Finasteride; Gynecomastia; Humans; Male; Middle Aged; Prolactin; Prostatic Hyperplasia; Testosterone | 1995 |
Induction of benign prostatic hyperplasia in intact dogs by near-physiological levels of 5 alpha-dihydrotestosterone and 17 beta-estradiol.
Topics: Analysis of Variance; Animals; Dihydrotestosterone; Disease Models, Animal; Dogs; Estradiol; Male; Prostatic Hyperplasia | 1995 |
[5-alpha-reductase inhibitors].
Topics: 5-alpha Reductase Inhibitors; Dihydrotestosterone; Finasteride; Humans; Male; Prostate; Prostatic Hyperplasia | 1994 |
Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
Topics: Aged; Androstane-3,17-diol; Cell Division; Cell Line; Cell Nucleus; Dihydrotestosterone; Epidermal Growth Factor; ErbB Receptors; Gonadal Steroid Hormones; Humans; Immunohistochemistry; In Vitro Techniques; Kinetics; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Estrogen; Signal Transduction; Testosterone | 1995 |
Potential activities of androgen metabolizing enzymes in human prostate.
Topics: Adult; Aged; Aging; Androgens; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Epithelium; Finasteride; Humans; Kinetics; Male; Middle Aged; Oxidoreductases; Prostate; Prostatic Hyperplasia | 1995 |
Effect of chlormadinone acetate-pellet implantation on the volume of prostate, peripheral blood levels of sex hormones and semen quality in the dog.
Topics: Aging; Animals; Chlormadinone Acetate; Dihydrotestosterone; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Implants; Luteinizing Hormone; Male; Progesterone Congeners; Prostate; Prostatic Hyperplasia; Semen; Sperm Motility; Spermatozoa; Testosterone; Time Factors | 1995 |
Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.
Topics: Androgens; Dihydrotestosterone; Epidermal Growth Factor; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Transforming Growth Factor alpha | 1993 |
Basis for hormonal management of advanced prostate cancer.
Topics: Androstenedione; Animals; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Biosynthesis; Rats; Testosterone | 1993 |
Benign prostatic hyperplasia in a transgenic mouse: a new hormonally sensitive investigatory model.
Topics: 5-alpha Reductase Inhibitors; Androstenes; Animals; Azasteroids; Dihydrotestosterone; Disease Models, Animal; Fibroblast Growth Factor 3; Fibroblast Growth Factors; Finasteride; Flutamide; Genes, Viral; Male; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Orchiectomy; Phenotype; Prostate; Prostatic Hyperplasia; Proto-Oncogene Proteins; Sexual Maturation; Testosterone | 1993 |
Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
Topics: Adult; Aged; Aged, 80 and over; Aging; Analysis of Variance; Chromatography, High Pressure Liquid; Dihydrotestosterone; Epithelium; Estradiol; Estrone; Gonadal Steroid Hormones; Humans; Least-Squares Analysis; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Stromal Cells; Testosterone | 1993 |
Effects of oral administration of chlormadinone acetate on canine prostatic hypertrophy.
Topics: Administration, Oral; Androstenedione; Animals; Chlormadinone Acetate; Dihydrotestosterone; Dog Diseases; Dogs; Estradiol; Luteinizing Hormone; Male; Prostate; Prostatic Hyperplasia; Reference Values | 1993 |
Hormone regulation of human prostate in organ culture.
Topics: Aged; Cell Division; Dexamethasone; Dihydrotestosterone; DNA; DNA, Neoplasm; Estradiol; Humans; Immunohistochemistry; Insulin; Male; Middle Aged; Organ Culture Techniques; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen | 1993 |
Stromal cells of the human prostate: initial isolation and characterization.
Topics: Cell Division; Cell Separation; Cells, Cultured; Centrifugation, Density Gradient; Dihydrotestosterone; Fibroblast Growth Factor 2; Fibroblasts; Humans; Immunohistochemistry; Male; Muscle, Smooth; Pituitary Hormones; Prostate; Prostatic Hyperplasia; Stromal Cells; Transforming Growth Factor beta | 1996 |
Possible mechanism of induction of benign prostatic hyperplasia by estradiol and dihydrotestosterone in dogs.
Topics: 7-Alkoxycoumarin O-Dealkylase; Animals; Aryl Hydrocarbon Hydroxylases; Catalase; Dihydrotestosterone; Dogs; Estradiol; Free Radicals; Glutathione Peroxidase; Kidney; Liver; Male; NAD(P)H Dehydrogenase (Quinone); Prostate; Prostatic Hyperplasia; Proteins | 1996 |
Concentration of the endogenous antiandrogen epitestosterone and androgenic C19-steroids in hyperplastic prostatic tissue.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androstenedione; Chromatography, High Pressure Liquid; Dihydrotestosterone; Epitestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Testosterone | 1996 |
Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: a new marker for predicting disease progression.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carrier Proteins; Dihydrotestosterone; Disease Progression; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatic Secretory Proteins | 1996 |
Expression of transcripts encoding steroid UDP-glucuronosyltransferases in human prostate hyperplastic tissue and the LNCaP cell line.
Topics: Androsterone; Base Sequence; Blotting, Northern; Cell Line; Dihydrotestosterone; DNA Probes; Gene Expression; Glucuronosyltransferase; Humans; Liver; Male; Molecular Sequence Data; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; RNA, Messenger; Steroids; Substrate Specificity; Testosterone | 1995 |
Analysis of the relative biomechanical effects of alpha 1 and alpha 2 antagonists in modifying the compliance of the prostate and micturition parameters of the hormonally manipulated male rat.
Topics: Adrenergic alpha-Antagonists; Animals; Dihydrotestosterone; Drug Combinations; Estradiol; Imidazoles; Male; Organ Size; Prazosin; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Urinary Bladder Neck Obstruction; Urination | 1996 |
5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
Topics: Base Sequence; Cells, Cultured; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; DNA Primers; DNA, Complementary; Enzyme Inhibitors; Epithelial Cells; Epithelium; Finasteride; Humans; Isoenzymes; Male; Molecular Sequence Data; Oxidoreductases; Polymerase Chain Reaction; Prostate; Prostatic Hyperplasia | 1995 |
Finasteride therapy does not alter bone turnover in men with benign prostatic hyperplasia--a Clinical Research Center study.
Topics: Aged; Biomarkers; Bone and Bones; Bone Density; Dihydrotestosterone; Finasteride; Humans; Male; Parathyroid Hormone; Prostatic Hyperplasia | 1996 |
Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue.
Topics: Data Interpretation, Statistical; Dihydrotestosterone; Epidermal Growth Factor; Fibroblast Growth Factor 2; Humans; Male; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Testosterone | 1995 |
Estramustine-binding protein in carcinoma and benign hyperplasia of the human prostate.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carrier Proteins; Dihydrotestosterone; Estramustine; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatic Secretory Proteins; Radioimmunoassay | 1996 |
Clinical study on estramustine binding protein (EMBP) in human prostate.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Androgens; Carrier Proteins; Dihydrotestosterone; Freezing; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Osmolar Concentration; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Secretory Proteins; Radioimmunoassay; Zinc | 1996 |
[Epitestosterone as an endogenous antiandrogen in men].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Androgen Antagonists; Child; Dihydrotestosterone; Epitestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Puberty; Testosterone | 1996 |
Coregulatory effects of epidermal growth factor, dihydrotestosterone, and prolactin on benign human prostatic hyperplasia tissue culture proliferation.
Topics: Aged; Aged, 80 and over; Cell Cycle; Cell Division; Cells, Cultured; Dihydrotestosterone; DNA; Drug Synergism; Epidermal Growth Factor; Humans; Male; Middle Aged; Prolactin; Prostate; Prostatic Hyperplasia; Thymidine; Time Factors | 1997 |
Lovastatin-induced apoptosis in prostate stromal cells.
Topics: Apoptosis; Cholesterol; Dihydrotestosterone; Diterpenes; DNA; Enzyme Inhibitors; Finasteride; Flow Cytometry; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lovastatin; Male; Mevalonic Acid; Prostate; Prostatic Hyperplasia; Stromal Cells; Testosterone | 1997 |
Epitestosterone in human blood and prostatic tissue.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Androstenedione; Child; Dihydrotestosterone; Epitestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Reference Values; Testosterone | 1997 |
Effects of DHT and EGF on human hyperplastic prostate cells cultured in vitro: growth, morphology and phenotype characterisation.
Topics: Cell Division; Cells, Cultured; Dihydrotestosterone; Dose-Response Relationship, Drug; Epidermal Growth Factor; Humans; Immunophenotyping; Male; Microscopy, Electron, Scanning; Middle Aged; Prostatic Hyperplasia | 1997 |
Effects of a new 5 alpha reductase inhibitor (epristeride) on human prostate cell cultures.
Topics: 5-alpha Reductase Inhibitors; Adult; Androstadienes; Cell Division; Cells, Cultured; Dihydrotestosterone; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Epithelium; Humans; Immunohistochemistry; Male; Polymerase Chain Reaction; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Hyperplasia; RNA, Messenger; Testosterone; Thymidine; Transcription, Genetic; Transforming Growth Factor beta | 1997 |
Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins.
Topics: Adult; Aged; Aging; Body Mass Index; Body Weight; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Electric Impedance; Environment; Estradiol; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Luteinizing Hormone; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Sex Hormone-Binding Globulin; Testosterone; Twins, Dizygotic; Twins, Monozygotic | 1997 |
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
Topics: Aged; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Enzyme-Linked Immunosorbent Assay; Estradiol; Greece; Humans; Insulin-Like Growth Factor I; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Radioimmunoassay; Risk Factors; Sex Hormone-Binding Globulin; Testosterone | 1997 |
Sex hormone-binding globulin mediates prostate androgen receptor action via a novel signaling pathway.
Topics: Animals; Carboxylic Ester Hydrolases; Cyclic AMP; Dihydrotestosterone; Dogs; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Sex Hormone-Binding Globulin | 1998 |
Chronology and urodynamic characterization of micturition in neurohormonally induced experimental prostate growth in the rat.
Topics: Adrenergic alpha-Antagonists; Animals; Chronic Disease; Dihydrotestosterone; Disease Models, Animal; Disease Progression; Drug Combinations; Follow-Up Studies; Male; Muscle Contraction; Organ Size; Prazosin; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Ureter; Urinary Bladder Neck Obstruction; Urodynamics | 1998 |
The effect of dihydrotestosterone on transcription of prostatic acid phosphatase mRNA in human hyperplastic gland.
Topics: Aged; Base Sequence; Dihydrotestosterone; DNA, Complementary; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; In Vitro Techniques; Male; Middle Aged; Prostate; Prostatic Hyperplasia; RNA, Messenger; Transcription, Genetic | 1997 |
Synergistic action of steroids and spermatocele fluid on in vitro proliferation of prostate stroma.
Topics: Adolescent; Androgens; Blotting, Western; Cells, Cultured; Chromatography, Affinity; Dihydrotestosterone; Estradiol; Exudates and Transudates; Humans; Immunohistochemistry; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Spermatocele; Stromal Cells; Testis; Testosterone | 1998 |
Association of benign prostatic hyperplasia with male pattern baldness.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Aging; Alopecia; Chi-Square Distribution; Dihydrotestosterone; Humans; Incidence; Korea; Male; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index | 1998 |
Effect of dual inhibition of 5-alpha-reductase and aromatase on spontaneously developed canine prostatic hypertrophy.
Topics: Anastrozole; Animals; Aromatase; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Dogs; Enzyme Inhibitors; Finasteride; Male; Nitriles; Oxidoreductases; Prostate; Prostatic Hyperplasia; Testosterone; Triazoles | 1998 |
Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.
Topics: Aged; Androgen Antagonists; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Epidermal Growth Factor; Humans; Male; Middle Aged; Oxidoreductases; Plant Extracts; Prostatic Hyperplasia; Serenoa; Testosterone | 1998 |
Selective interactions between prostate fibroblast and epithelial cells in co-culture maintain the BPH phenotype.
Topics: Cell Communication; Cell Division; Cholestenone 5 alpha-Reductase; Coculture Techniques; Culture Media, Conditioned; Dihydrotestosterone; Epithelial Cells; Fibroblasts; Humans; Hydrogen-Ion Concentration; Immunoenzyme Techniques; Keratins; Male; Microscopy, Electron; Oxidoreductases; Phenotype; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Testosterone | 1998 |
Can the intraprostatic concentration of epidermal growth factor influence the variance of serum prostate specific antigen levels in patients with benign prostatic hyperplasia?
Topics: Aged; Dihydrotestosterone; Epidermal Growth Factor; Humans; Linear Models; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia | 1999 |
The mechanism of epristeride against benign prostatic hyperplasia.
Topics: Androstadienes; Animals; Apoptosis; Cell Culture Techniques; Cell Size; Dihydrotestosterone; DNA Fragmentation; Electrophoresis, Agar Gel; Enzyme Inhibitors; Epithelium; Flow Cytometry; Immunohistochemistry; Male; Microscopy; Microspectrophotometry; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley | 1999 |
Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dihydrotestosterone; Dose-Response Relationship, Drug; Duodenum; Enzyme Inhibitors; Growth Substances; Hypotension, Orthostatic; Indoles; Male; Organ Size; Phenylephrine; Piperazines; Prostate; Prostatic Hyperplasia; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Testosterone; Urethra | 1999 |
Androgen-stimulated human prostate epithelial growth mediated by stromal-derived fibroblast growth factor-10.
Topics: Androgens; Cell Division; Cells, Cultured; Dihydrotestosterone; Epithelial Cells; Fibroblast Growth Factor 10; Fibroblast Growth Factors; Fluorescent Dyes; Gene Expression; Humans; Male; Polymerase Chain Reaction; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Recombinant Proteins; RNA, Messenger; Stromal Cells | 1999 |
5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Anastrozole; Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Blotting, Southern; Dihydrotestosterone; Enzyme Inhibitors; Etiocholanolone; Humans; Hydrogen-Ion Concentration; Isoenzymes; Male; Microsomes; Nitriles; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone; Triazoles; Tumor Cells, Cultured | 1999 |
Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Androstadienes; Animals; Aromatase Inhibitors; Chlormadinone Acetate; Dihydrotestosterone; Dogs; Enzyme Inhibitors; Estradiol; Estradiol Congeners; Female; Luteinizing Hormone; Male; Prostate; Prostatic Hyperplasia; Rabbits; Rats; Receptors, Estrogen; Testosterone | 2000 |
Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence.
Topics: Animals; Apoptosis; Chronic Disease; Dihydrotestosterone; Dopamine Antagonists; Gonadal Steroid Hormones; Hyperprolactinemia; Male; Orchiectomy; Organ Size; Prolactin; Prostate; Prostatic Hyperplasia; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Sulpiride; Testosterone | 2001 |
Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Topics: Androgen Antagonists; Animals; Apoptosis; Chlormadinone Acetate; Dihydrotestosterone; Dog Diseases; Dogs; Estradiol; Finasteride; Male; Prostate; Prostatic Hyperplasia; Testosterone | 2001 |
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
Topics: Aged; Androgens; Androstane-3,17-diol; Dihydrotestosterone; Humans; Immunologic Techniques; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Receptor, IGF Type 1; RNA, Messenger; Tissue Distribution | 2001 |
Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Topics: Adenocarcinoma; Androstane-3,17-diol; Animals; Cell Division; Dihydrotestosterone; Disease Models, Animal; Dog Diseases; Dogs; Estradiol; Gonadal Steroid Hormones; Immunohistochemistry; Keratins; Ki-67 Antigen; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen | 2001 |
Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland.
Topics: Androgens; Animals; Aromatase; Body Weight; Diet; Diethylstilbestrol; Dihydrotestosterone; Glycine max; Immunohistochemistry; Isoflavones; Male; Mice; Mice, Knockout; Organ Size; Prolactin; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Testosterone | 2001 |
A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy.
Topics: Aged; Androgen Antagonists; Animals; Dihydrotestosterone; Histone Acetyltransferases; Humans; Male; Mice; Mice, Nude; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nuclear Receptor Coactivator 1; Nuclear Receptor Coactivator 2; Orchiectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Transcription Factors; Transcriptional Activation; Transplantation, Heterologous | 2001 |
Apoptosis and hormonal milieu in ductal system of normal prostate and benign prostatic hyperplasia.
Topics: Adult; Apoptosis; Dihydrotestosterone; Estradiol; Humans; Male; Prostate; Prostatic Hyperplasia; Reference Values | 2001 |
Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Topics: Adenocarcinoma; Androstane-3,17-diol; Animals; Cell Division; Dihydrotestosterone; Disease Models, Animal; Dog Diseases; Dogs; Estradiol; Gonadal Steroid Hormones; Immunohistochemistry; Keratins; Ki-67 Antigen; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen | 2001 |
Stable expression of human 5alpha-reductase type II in COS1 cells due to chromosomal gene integration: a novel tool for inhibitor identification.
Topics: Androstenedione; Animals; Base Sequence; Cholestenone 5 alpha-Reductase; Chromosome Mapping; COS Cells; Dihydrotestosterone; DNA Primers; Drug Evaluation, Preclinical; Enzyme Inhibitors; Gene Expression; Humans; Isoenzymes; Male; Oxidoreductases; Plasmids; Prostatic Hyperplasia; Recombinant Proteins; Transfection | 2001 |
Binding of mepartricin to sex hormones, a key factor of its activity on benign prostatic hyperplasia.
Topics: Animals; Bile; Blood Proteins; Cattle; Centrifugation; Dihydrotestosterone; Estradiol; Gallbladder; Gonadal Steroid Hormones; Hormone Antagonists; Humans; In Vitro Techniques; Male; Mepartricin; Prostatic Hyperplasia; Protein Binding; Testosterone | 2001 |
[Measurement of T and DHT contents in normal and diseased human prostate tissues].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Radioimmunoassay; Testosterone | 2000 |
Cytopathological changes in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens.
Topics: Androgens; Androstenediol; Animals; Dihydrotestosterone; Disease Progression; Male; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Testosterone | 2002 |
[Is the prostatic adenoma of hormonal origin].
Topics: Aged; Animals; Castration; Dihydrotestosterone; Dogs; Estrogens; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Testosterone | 1975 |
In vivo uptake and metabolism of 3-h-5alpha-androstane-3alpha,17beta-diol and of 3-h-5alpha-androstane-3beta,17beta-diol by human prostatic hypertrophy.
Topics: Aged; Androstane-3,17-diol; Androstanes; Androsterone; Dihydrotestosterone; Humans; Male; Middle Aged; Muscles; Prostate; Prostatic Hyperplasia; Tritium | 1975 |
A systematic study of testosterone metabolism in benign prostatic hypertrophy (BPH): in vitro results.
Topics: Androstane-3,17-diol; Androstanes; Androstenedione; Culture Techniques; Dihydrotestosterone; Freezing; Heparin; Histocytochemistry; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Prostatic Hyperplasia; Testosterone; Time Factors; Tritium | 1975 |
5alpha-dihydrotestosterone stimulation of human prostate in organ culture.
Topics: Cell Division; Dihydrotestosterone; DNA; Glucose; Humans; Male; Necrosis; Organ Culture Techniques; Prostate; Prostatic Hyperplasia | 1975 |
Proceedings: Testosterone, dihydrotestosterone, zinc and cadmium in prostatic tissue.
Topics: Cadmium; Dihydrotestosterone; Male; Prostate; Prostatic Hyperplasia; Testosterone; Zinc | 1975 |
Androgen-binding proteins in human benign prostatic hypertrophy.
Topics: Aged; Binding Sites; Binding, Competitive; Carrier Proteins; Cytosol; Dihydrotestosterone; Humans; Kinetics; Male; Middle Aged; Prostatic Hyperplasia; Protein Binding; Receptors, Cell Surface; Testosterone | 1975 |
Evidence for a specific dihydrotestosterone-binding cytosol receptor in the human prostate.
Topics: Aged; Cyproterone; Cytosol; Dihydrotestosterone; Etiocholanolone; Humans; Hydrocortisone; In Vitro Techniques; Male; Middle Aged; Organ Specificity; Prostate; Prostatic Hyperplasia; Receptors, Cell Surface | 1975 |
3alpha-Reduction of dihydrotestosterone in human normal and hypertrophic prostatic tissues.
Topics: Aged; Androstanes; Dihydrotestosterone; Humans; Male; Oxidation-Reduction; Prostate; Prostatic Hyperplasia | 1975 |
Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
Topics: Androgens; Animals; Dihydrotestosterone; Dogs; Estradiol; Estrogens; Estrone; Male; Prostate; Prostatic Hyperplasia; Testosterone | 1975 |
Letter: Hormones, elderly testes, and carcinoma of the prostate.
Topics: Androgens; Androstenedione; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1975 |
The effect of steroid hormones on the growth pattern and RNA synthesis in human benign prostatic hyperplasia in organ culture.
Topics: Aged; Androstane-3,17-diol; Animals; Dihydrotestosterone; Epithelial Cells; Epithelium; Estradiol; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Organ Culture Techniques; Prostatic Hyperplasia; Rats; RNA; Stimulation, Chemical; Testosterone; Uridine | 1975 |
[Androgens].
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgen Antagonists; Androgen-Insensitivity Syndrome; Androgens; Animals; Dihydrotestosterone; Female; Male; Medroxyprogesterone; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Receptors, Cell Surface; Testosterone | 1975 |
Assay of androgen binding sites by exchange with methyltrienolone (R 1881).
Topics: Animals; Cytosol; Dihydrotestosterone; Estrenes; Humans; Male; Prostate; Prostatic Hyperplasia; Protein Binding; Rats; Receptors, Cell Surface; Temperature; Testosterone Congeners | 1976 |
[Recent results of prostatic adenoma research].
Topics: Animals; Dihydrotestosterone; Gestonorone Caproate; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Rats; Testosterone | 1975 |
Steroid receptors in the human prostate. 2. Some properties of the estrophilic molecule of benign prostatic hypertrophy.
Topics: Binding Sites; Binding, Competitive; Deoxyribonucleases; Dihydrotestosterone; Estradiol; Humans; Kinetics; Male; Pronase; Prostate; Prostatic Hyperplasia; Protein Binding; Proteins; Receptors, Cell Surface; Ribonucleases; Temperature | 1976 |
Influence of purified plasma proteins on testosterone uptake and metabolism by normal and hyperplastic human prostate in "constant-flow organ culture".
Topics: Androstane-3,17-diol; Blood Proteins; Carrier Proteins; Culture Media; Dihydrotestosterone; Humans; Male; Organ Culture Techniques; Prostate; Prostatic Hyperplasia; Serum Albumin; Testosterone | 1976 |
The induction of prostatic hypertrophy in the dog with androstanediol.
Topics: Androstane-3,17-diol; Androstanes; Animals; Castration; Dihydrotestosterone; Disease Models, Animal; Dogs; Estradiol; Estrone; Male; Prostatic Hyperplasia | 1976 |
Androgen of the human prostate.
Topics: Androgens; Androstane-3,17-diol; Desoxycorticosterone; Dihydrotestosterone; Female; Humans; Male; Organ Specificity; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Sex Factors; Testosterone | 1976 |
Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate.
Topics: Androstane-3,17-diol; Androstanes; Dihydrotestosterone; Humans; Hydroxysteroid Dehydrogenases; Male; Prostate; Prostatic Hyperplasia | 1976 |
Prostatic distribution of sex hormone-binding globulin and cortisol-binding globulin in benign hyperplasia.
Topics: Binding Sites; Cell Separation; Cytosol; Dihydrotestosterone; Humans; Hydrocortisone; Male; Prostate; Prostatic Hyperplasia; Sex Hormone-Binding Globulin; Transcortin | 1976 |
Metal-androgen interrelationships in carcinoma and hyperplasia of the human prostate.
Topics: Adult; Aged; Androgens; Cadmium; Dihydrotestosterone; Environmental Exposure; Humans; Male; Middle Aged; Occupational Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Zinc | 1976 |
Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
Topics: Aged; Androgens; Androstenedione; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1976 |
In vitro uptake of 3H testosterone and its conversion to dihydrotestosterone by prostatic carcinoma and other tissues.
Topics: Aged; Culture Techniques; Diethylstilbestrol; Dihydrotestosterone; Flutamide; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Tritium | 1976 |
Effect of megestrol acetate (Megace) on steroid metabolism and steroid-protein binding in the human prostate.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Dihydrotestosterone; Fluoxymesterone; Follicle Stimulating Hormone; Humans; In Vitro Techniques; Luteinizing Hormone; Male; Megestrol; Prolactin; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid; Testosterone | 1976 |
Intracellular localisation of 5alpha-dihydrotestosterone in human benign prostatic hypertrophy.
Topics: Acid Phosphatase; Dihydrotestosterone; DNA; Humans; Male; Muscles; Organ Specificity; Prostate; Prostatic Hyperplasia; Subcellular Fractions; Testosterone | 1976 |
Androgens in patients with benign prostatic hyperplasia before and after prostatectomy.
Topics: Aged; Androgens; Androstenedione; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Humans; Hydroxyprogesterones; Male; Middle Aged; Prostatectomy; Prostatic Hyperplasia; Testosterone | 1976 |
Formation of 5alpha-androstane-3alpha,17beta-diol by normal and hypertrophic human prostate.
Topics: Adult; Age Factors; Aged; Androstane-3,17-diol; Androstanes; Cytosol; Dihydrotestosterone; Female; Humans; Male; Microsomes; Middle Aged; NAD; NADP; Organ Size; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Time Factors | 1977 |
[Role of hormonal factors in the pathogenesis of prostatic hypertrophy].
Topics: Aged; Aging; Androgens; Dihydrotestosterone; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1977 |
Benign prostatic hyperplasia: etiological considerations.
Topics: Androstane-3,17-diol; Animals; Castration; Dihydrotestosterone; Estradiol; Humans; Male; Organ Size; Prostate; Prostatic Hyperplasia; Testosterone | 1976 |
Hormonal status in prostatic disease.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Age Factors; Aged; Androstenediols; Castration; Child; Chorionic Gonadotropin; Dihydrotestosterone; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1976 |
Androgen receptors in male sex tissues of rats and humans.
Topics: Androstane-3,17-diol; Androstenedione; Animals; Dihydrotestosterone; Epididymis; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Receptors, Androgen; Receptors, Steroid; Testis; Testosterone | 1976 |
Prostatic adenoma and carcinoma in cell culture and heterotransplantation.
Topics: Acid Phosphatase; Animals; Cells, Cultured; Culture Media; Dihydrotestosterone; Epithelial Cells; Epithelium; Estrogens; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Receptors, Androgen; Testosterone; Transplantation, Heterologous | 1976 |
Dihydrotestosterone-binding protein in cytosols of normal and hypertrophic human prostates, and influence of estrogens and anti-androgens on the binding.
Topics: Binding, Competitive; Cytosol; Dihydrotestosterone; Estrogens; Hormone Antagonists; Humans; In Vitro Techniques; Male; Prostate; Prostatic Hyperplasia; Protein Binding; Testosterone | 1977 |
Kinetics of 3H-testosterone and 3H-dihydrotestosterone metabolism in patients with benign prostatic hypertrophy. Effect of cyproterone acetate.
Topics: Aged; Cyproterone; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Kinetics; Liver; Luteinizing Hormone; Male; Prostate; Prostatic Hyperplasia; Testosterone | 1977 |
Metabolism of 5alpha-dihydrotestosterone in human benign hyperplastic prostate.
Topics: Dihydrotestosterone; Humans; In Vitro Techniques; Male; Perfusion; Prostatic Hyperplasia | 1977 |
The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
Topics: Aged; Androgens; Androstenedione; Dihydrotestosterone; Estradiol; Humans; Male; Middle Aged; Organ Culture Techniques; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1977 |
Comparative C19-radiosteroid metabolism by MA 160 and HeLa cell lines.
Topics: Androstane-3,17-diol; Androstanes; Androstenediols; Androstenedione; Androsterone; Carbon Radioisotopes; Cell Line; Dihydrotestosterone; Epithelial Cells; Epithelium; Fibroblasts; HeLa Cells; Humans; Male; Prostatic Hyperplasia; Skin; Testosterone; Tritium | 1977 |
Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma of patients with benign prostatic hypertrophy.
Topics: Aged; Androgens; Cytosol; Dihydrotestosterone; Humans; Male; Middle Aged; Muscles; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid; Sex Hormone-Binding Globulin; Testosterone | 1977 |
Altered metabolism of androgens in elderly men with benign prostatic hyperplasia.
Topics: Adult; Aged; Aging; Androstane-3,17-diol; Androstanes; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Testosterone | 1977 |
Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
Topics: Carcinoma; Cytosol; Dihydrotestosterone; Humans; In Vitro Techniques; Ligands; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Testosterone; Testosterone Congeners | 1977 |
Serum dihydrotestosterone in patients with benign prostatic hypertrophy.
Topics: Aged; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Testosterone | 1977 |
[Pathogenesis of prostatic hyperplasia in normal and adenomatous glands of men and dogs: 3-alpha reduction of dihydrotestesterone].
Topics: Androstane-3,17-diol; Animals; Dihydrotestosterone; Dogs; Humans; Male; Prostate; Prostatic Hyperplasia; Species Specificity; Testosterone | 1977 |
Androgen binding in cytosol and nucleus of cells from human benign hyperplastic prostate [proceedings].
Topics: Cell Nucleus; Cytosol; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid | 1977 |
Androgen glucuronide. II. DIfferences in its formation by human normal and benign hyperplastic prostates.
Topics: Androgens; Dihydrotestosterone; Glucuronates; Humans; Male; Prostate; Prostatic Hyperplasia; Testosterone | 1978 |
Androgen receptor content of the normal and hyperplastic canine prostate.
Topics: Aging; Animals; Binding Sites; Castration; Cytoplasm; Dihydrotestosterone; DNA; Dogs; Estrenes; In Vitro Techniques; Male; Organ Size; Prostate; Prostatic Hyperplasia; Proteins; Radioligand Assay; Receptors, Androgen; Receptors, Steroid; RNA; Testosterone Congeners | 1978 |
Androgen binding in cytosols and nuclei of human benign hyperplastic prostatic tissue.
Topics: Binding, Competitive; Cell Nucleus; Cytosol; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid | 1978 |
Comparison of testosterone, 5alpha-dihydrotestosterone and 5alpha-adrostane-3beta, 17beta-diol metabolisms in human normal and hyperplastic prostates.
Topics: Adolescent; Adult; Androstane-3,17-diol; Androstanes; Cytosol; Dihydrotestosterone; Humans; Male; Microsomes; NADP; Prostate; Prostatic Hyperplasia; Testosterone | 1978 |
Altered androgen metabolism in metastatic prostate cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Dihydrotestosterone; Humans; In Vitro Techniques; Lymphatic Metastasis; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1978 |
The effect of human serum on 3H-thymidine incorporation in human prostate tumors in tissue culture.
Topics: Animals; Blood; Cattle; Culture Techniques; Dihydrotestosterone; DNA; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Thymidine; Tritium | 1978 |
[Tissue culture of the human prostate--effects of sex hormones on subcultures of cells from benign prostatic hyperplasia and carcinoma of the prostate (author's transl)].
Topics: Adenocarcinoma; Cell Count; Cell Division; Culture Techniques; Diethylstilbestrol; Dihydrotestosterone; Estrone; Gonadal Steroid Hormones; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1978 |
Androgen receptor assay in human benign and malignant prostatic tumour cytosol using protamine sulphate precipitation.
Topics: Adult; Animals; Chemical Precipitation; Cytosol; Dihydrotestosterone; Estrogens; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Protamines; Rats; Receptors, Androgen; Receptors, Steroid; Testosterone | 1978 |
The use of methyltrienolone in the measurement of the free and bound cytoplasmic receptors for dihydrotestosterone in benign hypertrophied human prostate.
Topics: Cytoplasm; Dihydrotestosterone; Estrenes; Humans; Male; Methods; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid; Testosterone Congeners | 1978 |
Human prostatic carcinoma: significant differences in its androgen binding and metabolism compared to the human benign prostatic hypertrophy.
Topics: Adenocarcinoma; Aged; Androstanes; Carcinoma; Cytosol; Dihydrotestosterone; Estradiol; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Receptors, Steroid; Sex Hormone-Binding Globulin; Testosterone | 1978 |
Dihydrotestosterone concentration in prostate cancer tissue as a predictor of tumor differentiation and hormonal dependency.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgen Antagonists; Cell Differentiation; Dihydrotestosterone; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid | 1978 |
Serum steroids in normal males and patients with prostatic diseases.
Topics: Adult; Aged; Aging; Androstenedione; Androsterone; Dihydrotestosterone; Estradiol; Humans; Hydroxyprogesterones; Male; Middle Aged; Pregnenolone; Progesterone; Prostatic Hyperplasia; Prostatic Neoplasms; Reference Values; Steroids; Testosterone | 1978 |
[Autoradiographic demonstration of sex hormones in the human prostate].
Topics: Animals; Autoradiography; Dihydrotestosterone; Dogs; Humans; Male; Mice; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats | 1978 |
[Experimental study on the pathogenesis of prostatic adenoma].
Topics: 3-Hydroxysteroid Dehydrogenases; Androgens; Androstane-3,17-diol; Androstanes; Animals; Dihydrotestosterone; Dogs; Humans; Male; Prostatic Hyperplasia; Testosterone | 1977 |
Inhibition by various steroids on dihydrotestosterone binding to androphilic protein in human benign prostatic hypertrophy.
Topics: Androgens; Culture Techniques; Cyproterone; Cytosol; Dihydrotestosterone; Estradiol; Estrogens; Humans; Male; Progestins; Prostate; Prostatic Hyperplasia; Protein Binding | 1978 |
Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH).
Topics: Adult; Age Factors; Aged; Androstane-3,17-diol; Dihydrotestosterone; Estradiol; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Male; Middle Aged; Prolactin; Prostatic Hyperplasia; Sex Hormone-Binding Globulin; Testosterone | 1979 |
Increased ratio of 5 alpha-reductase: 3 alpha (beta)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate.
Topics: 3-Hydroxysteroid Dehydrogenases; Aged; Androstane-3,17-diol; Chromatography, Thin Layer; Dihydrotestosterone; Humans; Male; Middle Aged; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Time Factors | 1979 |
Cancer of the prostate: early diagnosis by zinc and hormone analysis?
Topics: Aged; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Zinc | 1979 |
DHT concentrations in human prostate cancer tissue.
Topics: Castration; Dihydrotestosterone; Estrogens; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms | 1978 |
Receptor proteins for androgens in prostatic disease.
Topics: Dihydrotestosterone; Estrenes; Hydrocortisone; Male; Progesterone; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Testosterone Congeners | 1978 |
Comparison of spontaneous and experimentally induced canine prostatic hyperplasia.
Topics: Androstane-3,17-diol; Animals; Castration; Dihydrotestosterone; Dog Diseases; Dogs; Estradiol; Male; Organ Size; Prostate; Prostatic Hyperplasia; Testis; Testosterone | 1979 |
Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.
Topics: Androstenediols; Animals; Castration; Dihydrotestosterone; Dog Diseases; Dogs; Male; Prostate; Prostatic Hyperplasia; Testosterone; Time Factors | 1979 |
C19O2-Steroid transformations in the human normal, hyperplastic and cancerous prostate.
Topics: Androstane-3,17-diol; Androstanols; Dihydrotestosterone; Humans; Hydroxysteroid Dehydrogenases; In Vitro Techniques; Male; Mixed Function Oxygenases; NADP; Oxidation-Reduction; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1979 |
Testosterone 5 alpha-reductase and the accumulation of dihydrotestosterone in benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Dihydrotestosterone; Humans; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Testosterone | 1979 |
A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Androstane-3,17-diol; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Sex Hormone-Binding Globulin; Testosterone | 1979 |
Metabolism and action of steroid hormones on human benign prostatic hyperplasia and prostatic carcinoma grown in organ culture.
Topics: Adult; Aged; Dihydrotestosterone; DNA; Estradiol; Humans; Male; Middle Aged; Organ Culture Techniques; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; RNA; Testosterone | 1979 |
Properties of androphilic proteins in cytosols of human benign prostatic hypertrophy.
Topics: Cytosol; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Protein Binding; Receptors, Androgen; Receptors, Steroid | 1979 |
Steroid levels in cancer of the prostate--markers of tumor differentiation and adequacy of anti-androgen therapy.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Carcinoma; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms | 1979 |
Protamine sulfate precipitation of androgen receptors in cytosols of human benign and malignant prostatic tumors.
Topics: Chemical Precipitation; Cytosol; Dihydrotestosterone; Humans; Ligands; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Protamines; Receptors, Androgen; Receptors, Steroid; Testosterone | 1979 |
Measurement of androgen receptor in cytosol of human prostatic tissues with a sepharose-linked antibody system.
Topics: Chromatography, Affinity; Cytosol; Dihydrotestosterone; Humans; Immunosorbent Techniques; Kinetics; Male; Progesterone; Prostate; Prostatic Hyperplasia; Protamines; Receptors, Androgen; Receptors, Progesterone; Receptors, Steroid; Testosterone | 1979 |
Measurement and characterization of estrogen receptors in the human prostate.
Topics: Adult; Aged; Chromatography, DEAE-Cellulose; Cytosol; Diethylstilbestrol; Dihydrotestosterone; Epithelium; Humans; Kinetics; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Estrogen | 1979 |
Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
Topics: Aged; Dihydrotestosterone; Humans; In Vitro Techniques; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Tritium | 1979 |
Androgen receptors in benign and malignant prostatic tissue.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgen Antagonists; Animals; Cyproterone; Dihydrotestosterone; Estrenes; Flutamide; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Receptors, Androgen; Receptors, Steroid | 1979 |
Subnormal tissue 3 alpha-androstanediol and androsterone in prostatic hyperplasia.
Topics: Androgens; Androstane-3,17-diol; Androstanols; Androsterone; Antibody Specificity; Dihydrotestosterone; Humans; Immune Sera; Male; Prostate; Prostatic Hyperplasia; Radioimmunoassay | 1978 |
In vitro studies on the effect of cofactors on the 5 alpha-reductase and 3 alpha- and 3 beta-hydroxysteroid reductase activities in the hyperplastic human prostate.
Topics: Androstanes; Chromatography, High Pressure Liquid; Dihydrotestosterone; Humans; Hydroxysteroid Dehydrogenases; In Vitro Techniques; Male; NADP; Prostate; Prostatic Hyperplasia | 1992 |
The distribution of PSA, cathepsin-D, and pS2 in BPH and cancer of the prostate.
Topics: Cathepsin D; Dihydrotestosterone; Humans; Male; Neoplasm Proteins; Osmolar Concentration; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Proteins; Testosterone; Tissue Distribution; Trefoil Factor-1; Tumor Suppressor Proteins | 1992 |
Measurement of androgen sensitivity in the human prostate in in vitro three-dimensional histoculture.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Dihydrotestosterone; Flutamide; Histological Techniques; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Thymidine | 1992 |
Effects of the new steroidal antiandrogen TZP-4238 on hormone-induced canine prostatic hyperplasia.
Topics: Androstane-3,17-diol; Animals; Chlormadinone Acetate; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Dogs; Male; Organ Size; Oxidoreductases; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Ultrasonography | 1992 |
The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates.
Topics: Cell Division; Cells, Cultured; Dihydrotestosterone; Epidermal Growth Factor; Estradiol; Female; Fetus; Fibroblasts; Flutamide; Genes, fos; Growth Substances; Humans; Immunohistochemistry; Male; Pregnancy; Prostate; Prostatic Hyperplasia; RNA, Messenger | 1992 |
Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.
Topics: 5-alpha Reductase Inhibitors; Androgens; Binding, Competitive; Cell Nucleus; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testosterone | 1992 |
Dihydrotestosterone accumulation in genital skin fibroblasts derived from elderly men with prostatic hyperplasia.
Topics: Aged; Aging; Androstane-3,17-diol; Cells, Cultured; Dihydrotestosterone; Fibroblasts; Genitalia, Male; Humans; Male; Prostatic Hyperplasia; Skin | 1992 |
Androgen concentrations in expressed prostatic secretions: no correlation with tissue levels.
Topics: Body Fluids; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Spectrophotometry, Atomic; Testosterone; Zinc | 1992 |
Inhibition of experimentally induced mouse prostatic hyperplasia by castration or steroid antagonist administration.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Azasteroids; Dihydrotestosterone; DNA; Drug Therapy, Combination; Estrogen Antagonists; Female; Male; Mice; Mice, Inbred BALB C; Orchiectomy; Piperidines; Progesterone; Prostatic Hyperplasia; Raloxifene Hydrochloride; Urogenital System | 1990 |
Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
Topics: 5-alpha Reductase Inhibitors; Androgens; Androstenes; Antigens, Neoplasm; Azasteroids; Dihydrotestosterone; Epithelium; Estradiol; Finasteride; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Hyperplasia; Testosterone | 1990 |
Immunohistochemical localization of the androgen receptor in rat and human tissues.
Topics: Animals; Dihydrotestosterone; Epididymis; Genitalia, Male; Humans; Immunoenzyme Techniques; Male; Orchiectomy; Organ Specificity; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred Strains; Receptors, Androgen; Reference Values; Seminal Vesicles; Testis | 1990 |
Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.
Topics: Age Factors; Body Weight; Case-Control Studies; Dihydrotestosterone; Estradiol; Humans; Japan; Male; Netherlands; Prostatic Hyperplasia; Prostatic Neoplasms; Saliva; Sex Hormone-Binding Globulin; Testosterone | 1991 |
[Activity of 5 alpha-reductase in human hyperplastic prostates].
Topics: Aged; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Male; Middle Aged; Oxidoreductases; Prostate; Prostatic Hyperplasia | 1991 |
Magnetic resonance imaging of the efficacy of specific inhibition of 5 alpha-reductase in canine spontaneous benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Androstenes; Animals; Azasteroids; Dihydrotestosterone; Dog Diseases; Dogs; Finasteride; Magnetic Resonance Imaging; Male; Prostate; Prostatic Hyperplasia | 1991 |
Optimism expressed over prostate drug.
Topics: Androstenes; Antineoplastic Agents; Azasteroids; Dihydrotestosterone; Finasteride; Humans; Male; Pilot Projects; Prostatic Hyperplasia; Prostatic Neoplasms; Recurrence | 1991 |
Correlated biochemical and stereological studies on testosterone metabolism in the stromal and epithelial compartment of human benign prostatic hyperplasia.
Topics: Androstane-3,17-diol; Chromatography, Thin Layer; Dihydrotestosterone; Epithelium; Humans; Male; Prostate; Prostatic Hyperplasia; Testosterone; Time Factors; Tritium | 1985 |
[Is there a hormonal etiology in prostatic hypertrophy?].
Topics: Adult; Aged; Animals; Dihydrotestosterone; Dogs; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Prostatic Hyperplasia; Receptors, Cell Surface | 1985 |
Binding of 7 alpha, 17 alpha-dimethyl-19-nortestosterone (mibolerone) to androgen and progesterone receptors in human and animal tissues.
Topics: Animals; Blood Proteins; Breast; Cattle; Cell Nucleus; Cytosol; Dihydrotestosterone; Estrenes; Female; Humans; Male; Metribolone; Nandrolone; Pregnenediones; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred Strains; Receptors, Androgen; Receptors, Progesterone; Substrate Specificity; Uterus | 1986 |
Characterization of steroid receptors in human prostate using mibolerone.
Topics: Animals; Chemical Phenomena; Chemistry; Dihydrotestosterone; Estrenes; Female; Humans; Male; Metribolone; Nandrolone; Promegestone; Prostate; Prostatic Hyperplasia; Rabbits; Receptors, Androgen; Receptors, Progesterone; Testosterone | 1986 |
In vitro effects of an aromatase inhibitor on 5 alpha-reductase activity in human hypertrophic prostatic tissue.
Topics: 5-alpha Reductase Inhibitors; Aged; Androstane-3,17-diol; Androstenedione; Aromatase Inhibitors; Azasteroids; Dihydrotestosterone; Humans; In Vitro Techniques; Male; Middle Aged; Prostatic Hyperplasia; Testosterone | 1986 |
Association states of androgen receptors in nuclei of human benign hypertrophic prostate.
Topics: Cell Fractionation; Cell Nucleus; Dihydrotestosterone; DNA; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen | 1986 |
Effect of 16 beta-ethyl-17 beta-hydroxy-4-estren-3-one (TSAA-291) on the binding of promegestone (R5020) and methyltrienolone (R1881) to hyperplastic and neoplastic human prostate.
Topics: Binding, Competitive; Centrifugation, Density Gradient; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Estrenes; Humans; Male; Mathematics; Metribolone; Nandrolone; Norpregnadienes; Promegestone; Prostatic Hyperplasia | 1986 |
[Hormone-dependency of the human prostate].
Topics: Dihydrotestosterone; Humans; Male; Neoplasms, Hormone-Dependent; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid | 1986 |
Effect of antiandrogen and/or antiestrogen blockade on human prostate epithelial and stromal cell protein synthesis.
Topics: Dihydrotestosterone; Epithelium; Humans; Ketoconazole; Kinetics; Male; Megestrol; Megestrol Acetate; Prostate; Prostatic Hyperplasia; Protein Biosynthesis; Tamoxifen | 1986 |
Light-microscopic stereologic analysis of spontaneous and steroid-induced canine prostatic hyperplasia.
Topics: Androstane-3,17-diol; Animals; Castration; Dihydrotestosterone; Dogs; Estradiol; Male; Microscopy; Prostate; Prostatic Hyperplasia; Testosterone | 1987 |
DNA synthesis in the canine prostate: effects of androgen and estrogen treatment.
Topics: Androgens; Animals; Dihydrotestosterone; DNA; Dogs; Estradiol; Estrogens; Male; Prostate; Prostatic Hyperplasia; Testosterone | 1987 |
Comparison of nuclear 5 alpha-reductase activities in the stromal and epithelial fractions of human prostatic tissue.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Cell Nucleus; Dihydrotestosterone; Edetic Acid; Epithelium; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Zinc | 1987 |
The partial dependency of human prostatic growth factor on steroid hormones in stimulating thymidine incorporation into DNA.
Topics: Adult; Aged; Dihydrotestosterone; DNA; DNA, Neoplasm; Electrophoresis, Polyacrylamide Gel; Estradiol; Growth Substances; Humans; Isoelectric Focusing; Male; Middle Aged; Molecular Weight; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Steroids; Thymidine | 1987 |
Determination of testosterone and its tissue metabolites (DHT and 3 alpha-diol) in human plasma and prostatic tissue by isotopic dilution mass spectrometry.
Topics: Androstenediol; Androstenediols; Dihydrotestosterone; Gas Chromatography-Mass Spectrometry; Humans; Indicator Dilution Techniques; Male; Prostate; Prostatic Hyperplasia; Testosterone | 1987 |
Study of the effect of an anti-androgen (oxendolone) on experimentally induced canine prostatic hyperplasia. II. Endocrinological analysis.
Topics: Animals; Dihydrotestosterone; Dogs; Estradiol; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Nandrolone; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Estrogen; Testosterone | 1988 |
Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate.
Topics: Animals; Collagen; Dihydrotestosterone; Disease Models, Animal; Drug Implants; Estradiol; Fibroblasts; Fibrosis; Inflammation; Male; Muscle, Smooth; Orchiectomy; Organ Size; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Rats; Rats, Inbred Strains | 1988 |
Androgen concentration in blacks with benign and malignant prostatic disease.
Topics: Aged; Androgens; Androstenediols; Androstenedione; Black People; Dihydrotestosterone; Humans; Male; Middle Aged; Nigeria; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Testosterone | 1988 |
A hybrid ligand method for androgen receptor measurement.
Topics: Animals; Binding, Competitive; Colonic Neoplasms; Cytosol; Dihydrotestosterone; Estrenes; False Negative Reactions; Female; Humans; Male; Metribolone; Orchiectomy; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred Strains; Receptors, Androgen; Rectal Neoplasms; Sex Hormone-Binding Globulin; Triamcinolone Acetonide; Tritium; Uterus | 1988 |
Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats.
Topics: Animals; Body Weight; Dihydrotestosterone; Gonadal Steroid Hormones; Male; Mitotic Index; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Rats; Receptors, Androgen; Receptors, Estrogen | 1988 |
Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.
Topics: Aged; Aged, 80 and over; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Epithelium; Humans; Kinetics; Male; Middle Aged; Oxidoreductases; Progesterone; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Radioimmunoassay | 1988 |
Influences of dihydrotestosterone, testosterone, estradiol, progesterone, or prolactin on the cell kinetics of human hyperplastic prostatic tissue in organ culture.
Topics: Aged; Aged, 80 and over; Autoradiography; Cell Division; Culture Techniques; Dihydrotestosterone; Estradiol; Gonadal Steroid Hormones; Humans; Kinetics; Male; Middle Aged; Progesterone; Prolactin; Prostate; Prostatic Hyperplasia; Testosterone | 1988 |
Effect of aging on kinetic parameters of 5 alpha-reductase in epithelium and stroma of normal and hyperplastic human prostate.
Topics: Adult; Aged; Aged, 80 and over; Aging; Dihydrotestosterone; Epithelium; Humans; Kinetics; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Testosterone | 1988 |
Effect of diethylstilbestrol diphosphate on activity of 5 alpha-reductase in human prostate.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Diethylstilbestrol; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Time Factors | 1987 |
Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Aged, 80 and over; Androgens; Delayed-Action Preparations; Dihydrotestosterone; Female; Gonadotropin-Releasing Hormone; Humans; Kidney; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testosterone; Uterus | 1989 |
Autoradiographic studies of androgen-binding sites in human benign prostatic hyperplasia in vitro.
Topics: Aged; Aged, 80 and over; Autoradiography; Dihydrotestosterone; Estrenes; Humans; Male; Metribolone; Middle Aged; Prostatic Hyperplasia; Receptors, Androgen; Testosterone Congeners | 1989 |
Epidermal growth factor receptors in human hyperplastic prostate tissue and their modulation by chronic treatment with a gonadotropin-releasing hormone analog.
Topics: Aged; Binding Sites; Buserelin; Dihydrotestosterone; Epidermal Growth Factor; ErbB Receptors; Goserelin; Humans; Male; Middle Aged; Models, Biological; Prostatic Hyperplasia; Testosterone | 1989 |
Dihydrotestosterone measured in core biopsies from prostatic tissues.
Topics: Aged; Aged, 80 and over; Biopsy; Cell Nucleus; Dihydrotestosterone; DNA; DNA, Neoplasm; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms | 1988 |
Dose-dependent hormonal induction of benign prostatic hyperplasia (BPH) in castrated dogs.
Topics: Androstane-3,17-diol; Androstanols; Animals; Chromatography, High Pressure Liquid; Dihydrotestosterone; Dogs; Dose-Response Relationship, Drug; Drug Implants; Estradiol; Male; Orchiectomy; Organ Size; Prostatic Hyperplasia; Semen; Testosterone | 1989 |
Analysis of the androgen binding in human benign prostatic hypertrophy.
Topics: Binding, Competitive; Buffers; Charcoal; Cytosol; Dextrans; Dihydrotestosterone; Electrophoresis, Agar Gel; Enzyme Activation; Estrenes; Humans; Male; Metribolone; Molybdenum; Progesterone; Prostatic Hyperplasia; Protease Inhibitors; Receptors, Androgen; Tartrates; Temperature; Testosterone Congeners | 1989 |
[A study on usefulness of the crude nuclear DHT measurement in prostatic cancer patients].
Topics: Androgens; Cell Nucleus; Dihydrotestosterone; Humans; Male; Methods; Neoplasms, Hormone-Dependent; Predictive Value of Tests; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen | 1989 |
Metabolism of androgens in human hyperplastic prostate: evidence for a differential localization of the enzymes involved in the metabolism.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Cell Fractionation; Dihydrotestosterone; Humans; Male; Microscopy, Electron; Nuclear Envelope; Prostate; Prostatic Hyperplasia; Subcellular Fractions; Testosterone | 1989 |
Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aging; Androstane-3,17-diol; Androstanols; Androstenedione; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1985 |
The effect of prolactin on human BPH epithelial cell proliferation.
Topics: Cells, Cultured; Dihydrotestosterone; Epithelial Cells; Epithelium; Humans; Male; Metaphase; Prolactin; Prostatic Hyperplasia; Testosterone; Thymidine | 1985 |
Chromatin-associated protein kinases in human normal and benign hyperplastic prostate.
Topics: Adenosine Triphosphate; Autoradiography; Cell Nucleus; Chromatin; Dihydrotestosterone; DNA; Humans; Hydrogen-Ion Concentration; Magnesium; Male; Nucleoproteins; Phosphorylation; Prostate; Prostatic Hyperplasia; Protein Kinases; Sodium Chloride | 1985 |
Acute effects of testicular and adrenal cortical blockade on protein synthesis and dihydrotestosterone content of human prostate tissue.
Topics: Adrenal Cortex; Aged; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Dihydrotestosterone; Epithelium; Humans; Hydrocortisone; Male; Megestrol; Megestrol Acetate; Middle Aged; Prostate; Prostatic Hyperplasia; Protein Biosynthesis; Testis; Testosterone | 1985 |
The metabolism of testosterone by human prostate in organ culture.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Androstanes; Androsterone; Autoradiography; Dihydrotestosterone; Humans; Male; Organ Culture Techniques; Prostate; Prostatic Hyperplasia; Testosterone | 1970 |
Testosterone metabolism in vivo by human prostatic tissue.
Topics: Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Testosterone; Tritium | 1970 |
Androgen dynamics in vitro in the normal and hyperplastic human prostate gland.
Topics: Adult; Aged; Androgens; Androstanes; Carbon Isotopes; Chromatography, Thin Layer; Dihydrotestosterone; Humans; In Vitro Techniques; Ketones; Kinetics; Male; Middle Aged; Models, Biological; Perfusion; Prostate; Prostatic Hyperplasia; Testosterone; Tritium | 1971 |
The role of the steroid-sensitive cation-dependent ATPase in human prostatic tissue.
Topics: 17-Hydroxycorticosteroids; Adenosine Triphosphatases; Androgens; Androstanes; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Humans; Hydroxysteroid Dehydrogenases; In Vitro Techniques; Male; Microsomes; Oxidoreductases; Potassium; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Sodium; Sterols; Stimulation, Chemical; Tritium | 1972 |
Androgen dynamics in vitro in the human prostate gland. Effect of cyproterone and cyproterone acetate.
Topics: Acetates; Aged; Androgen Antagonists; Androstenedione; Biological Transport; Carbon Isotopes; Cyproterone; Dihydrotestosterone; Humans; Male; Middle Aged; Pregnadienes; Prostate; Prostatic Hyperplasia; Testosterone; Time Factors; Tritium | 1973 |
In-vitro studies on testosterone and 5alpha-dihydrotestosterone binding in benign prostatic hypertrophy (BPH).
Topics: Androstanes; Carrier Proteins; Cytosol; Dihydrotestosterone; Electrophoresis, Starch Gel; Humans; Male; Muscles; Prostatic Hyperplasia; Protein Binding; Receptors, Cell Surface; Testosterone; Tissue Extracts; Tritium; Ultracentrifugation | 1973 |
[Metabolism of 3H-testosteron and 3H-5alpha-DHT in the normal and adenomatous prostate (author's transl)].
Topics: Androstenols; Animals; Chromatography, Thin Layer; Dihydrotestosterone; Male; Prostate; Prostatic Hyperplasia; Protein Binding; Rats; Testosterone; Tritium | 1973 |
Hormonal effects on prostatic acid phosphatase synthesis in tissue culture.
Topics: Acid Phosphatase; Cell Line; Dehydroepiandrosterone; Diethylstilbestrol; Dihydrotestosterone; Electrophoresis, Polyacrylamide Gel; Estradiol; Estriol; Estrone; Humans; Male; Methane; Prostate; Prostatic Hyperplasia; Proteins; Staining and Labeling; Testosterone | 1974 |
Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro.
Topics: Androstanes; Androstenedione; Androsterone; Dehydroepiandrosterone; Dihydrotestosterone; Epithelium; Humans; In Vitro Techniques; Male; Prostate; Prostatectomy; Prostatic Hyperplasia; Testosterone; Tritium | 1974 |
Hormonal responsiveness of prostatic carcinoma. In vitro technique for prediction.
Topics: Androgens; Binding Sites; Castration; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Remission, Spontaneous; Tritium | 1974 |
Cystic dilatation of sex accessory organs in common and inbred Syrian Hamsters.
Topics: 17-Hydroxycorticosteroids; Aging; Androstanes; Androstenedione; Animals; Chromatography, Thin Layer; Dihydrotestosterone; Epithelium; Haplorhini; Inbreeding; Male; Prostatic Hyperplasia; Species Specificity; Sterols; Syria; Testosterone; Tritium | 1974 |
The determination in human males of specific testosterone and 5aplha-dihydrotestosterone binding to sex hormone binding globulin by a differential dissociation technique.
Topics: Adult; Aged; Aging; Androgens; Animals; Binding, Competitive; Carcinoma; Dihydrotestosterone; Estrogens; Humans; Hydrocortisone; Male; Methods; Middle Aged; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Binding; Radioimmunoassay; Rats; Serum Globulins; Testosterone; Time Factors; Tritium | 1974 |
Androgen assimilation by normal and hyperplastic dog prostate glands.
Topics: Androstenedione; Androstenols; Animals; Binding, Competitive; Cell Membrane; Chromatography, Thin Layer; Dihydrotestosterone; Dogs; Estradiol; Histocytochemistry; In Vitro Techniques; Male; NADP; Progesterone; Prostate; Prostatic Hyperplasia; Stimulation, Chemical; Testosterone; Time Factors; Tritium | 1974 |
The interaction of dihydrotestosterone and oestradiol-17beta with macromolecules in human hyperplastic prostate tissue.
Topics: Carbon Radioisotopes; Cell Nucleus; Chromatography, Gel; Chromatography, Paper; Chromatography, Thin Layer; Cyproterone; Cytoplasm; Depression, Chemical; Diethylstilbestrol; Dihydrotestosterone; Estradiol; Estrone; Ethinyl Estradiol; Humans; Hydrocortisone; In Vitro Techniques; Male; Prostate; Prostatic Hyperplasia; Protein Binding; Tritium | 1974 |
In vitro studies of testosterone and 5alpha-dihydrotestosterone binding in benign prostatic hypertrophy.
Topics: Aged; Androstenedione; Binding Sites; Blood Proteins; Centrifugation, Density Gradient; Charcoal; Cytosol; Dihydrotestosterone; Electrophoresis; Estradiol; Humans; Immunodiffusion; Immunoglobulin G; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Protein Binding; Serum Albumin; Testosterone; Tritium | 1974 |
Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
Topics: Androstanes; Androstenedione; Diethylstilbestrol; Dihydrotestosterone; Gestonorone Caproate; Humans; In Vitro Techniques; Kinetics; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Testosterone; Tritium | 1974 |
Inhibition of testosterone metabolism in the human prostate.
Topics: Androgen Antagonists; Androstanes; Anilides; Carbon Radioisotopes; Cyproterone; Desoxycorticosterone; Dihydrotestosterone; Estradiol; Estriol; Humans; Hydrocarbons, Fluorinated; In Vitro Techniques; Male; Medrogestone; Medroxyprogesterone; Nitro Compounds; Progesterone; Progestins; Prostate; Prostatic Hyperplasia; Testosterone; Tritium | 1974 |
Secretion of dihydrotestosterone by human prostate in benign prostatic hypertrophy.
Topics: Adolescent; Aged; Animals; Dihydrotestosterone; Humans; Immune Sera; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Rabbits; Radioimmunoassay; Testosterone; Tritium | 1974 |
Testosterone metabolism in cultured hyperplasia of the human prostate.
Topics: 17-Hydroxycorticosteroids; Androstanes; Androstenedione; Androsterone; Animals; Carbon Radioisotopes; Cattle; Chromatography, Paper; Chromatography, Thin Layer; Dehydroepiandrosterone; Dihydrotestosterone; Horses; Humans; Male; Organ Culture Techniques; Prostate; Prostatic Hyperplasia; Sterols; Testosterone; Time Factors; Tritium | 1974 |
Benign hyperplasia of the human prostate exposed to steroid hormones in organ culture.
Topics: Acid Phosphatase; Aged; Culture Media; Cyproterone; Dihydrotestosterone; Esterases; Estradiol; Glucuronidase; Histocytochemistry; Humans; Leucyl Aminopeptidase; Male; Middle Aged; Organ Culture Techniques; Progesterone; Prostate; Prostatic Hyperplasia; Steroids; Testosterone; Thymidine; Tritium | 1974 |
Testosterone metabolism in prostate; formation of androstan-17-beta-ol-3-one and androst-4-ene-3, 17-dione, and inhibitory effect of natural and synthetic estrogens.
Topics: Androgens; Animals; Dihydrotestosterone; Dogs; Estrogens; Humans; In Vitro Techniques; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Testosterone | 1965 |
Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.
Topics: Adolescent; Adult; Aged; Aging; Autopsy; Biopsy; Carbon Isotopes; Culture Techniques; Dihydrotestosterone; Humans; Male; Methods; Middle Aged; Organ Size; Prostate; Prostatic Hyperplasia; Testosterone; Tritium | 1970 |
Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
Topics: Aging; Animals; Biological Transport; Castration; Culture Techniques; Dihydrotestosterone; DNA; Dogs; Male; NADP; Organ Size; Oxidoreductases; Prostate; Prostatic Hyperplasia; RNA; Testosterone; Tritium | 1970 |